HRP20150348T1 - Derivati izoksazolo-piridina - Google Patents
Derivati izoksazolo-piridina Download PDFInfo
- Publication number
- HRP20150348T1 HRP20150348T1 HRP20150348TT HRP20150348T HRP20150348T1 HR P20150348 T1 HRP20150348 T1 HR P20150348T1 HR P20150348T T HRP20150348T T HR P20150348TT HR P20150348 T HRP20150348 T HR P20150348T HR P20150348 T1 HRP20150348 T1 HR P20150348T1
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- isoxazol
- ylmethoxy
- nicotinamide
- phenyl
- Prior art date
Links
- NABZXASCLFSKLF-UHFFFAOYSA-N [1,2]oxazolo[4,3-b]pyridine Chemical class C1=CC=NC2=CON=C21 NABZXASCLFSKLF-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 40
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 claims 36
- 229910052736 halogen Inorganic materials 0.000 claims 31
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 23
- 125000000623 heterocyclic group Chemical group 0.000 claims 17
- 150000002367 halogens Chemical class 0.000 claims 16
- 125000005843 halogen group Chemical group 0.000 claims 15
- 150000003839 salts Chemical class 0.000 claims 12
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 11
- -1 C1-7-alkoxy Chemical group 0.000 claims 10
- 239000011570 nicotinamide Substances 0.000 claims 8
- 229960003966 nicotinamide Drugs 0.000 claims 8
- 125000004043 oxo group Chemical group O=* 0.000 claims 8
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 7
- 229910052757 nitrogen Inorganic materials 0.000 claims 7
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 6
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims 5
- 238000006243 chemical reaction Methods 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 4
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 claims 2
- ZECHOCFAIQZSIQ-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 ZECHOCFAIQZSIQ-UHFFFAOYSA-N 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000002950 monocyclic group Chemical group 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims 2
- PGCHIYFRNQWREH-QFIPXVFZSA-N (2s)-2-[[6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carbonyl]amino]-3-phenylpropanoic acid Chemical compound C([C@H](NC(=O)C1=CC=C(N=C1)OCC=1C(=NOC=1C)C=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 PGCHIYFRNQWREH-QFIPXVFZSA-N 0.000 claims 1
- RTAFFWCZWXAGAY-UHFFFAOYSA-N (3-hydroxyazetidin-1-yl)-[6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CC(O)C1 RTAFFWCZWXAGAY-UHFFFAOYSA-N 0.000 claims 1
- JIQMGMVRMZNYMC-UHFFFAOYSA-N 2-(1-hydroxy-2-methylpropan-2-yl)-6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC=CC=2)C=1COC1=CC=C(C(N)=O)C(C(C)(C)CO)=N1 JIQMGMVRMZNYMC-UHFFFAOYSA-N 0.000 claims 1
- OEXRKNCZCDFERG-UHFFFAOYSA-N 2-(2-hydroxyethyl)-6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC=CC=2)C=1COC1=CC=C(C(N)=O)C(CCO)=N1 OEXRKNCZCDFERG-UHFFFAOYSA-N 0.000 claims 1
- RJYBKFKHBUDDSN-UHFFFAOYSA-N 2-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(2,2,2-trifluoroethyl)pyridine-4-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC(C(=O)NCC(F)(F)F)=CC=N1 RJYBKFKHBUDDSN-UHFFFAOYSA-N 0.000 claims 1
- HGHPLOZJXNYTMQ-UHFFFAOYSA-N 2-[3-[[6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carbonyl]amino]piperidin-1-yl]acetic acid Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCCN(CC(O)=O)C1 HGHPLOZJXNYTMQ-UHFFFAOYSA-N 0.000 claims 1
- SCVZZDMNEYXFGY-UHFFFAOYSA-N 2-ethyl-6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound C1=C(C(N)=O)C(CC)=NC(OCC=2C(=NOC=2C)C=2N=CC=CC=2)=C1 SCVZZDMNEYXFGY-UHFFFAOYSA-N 0.000 claims 1
- LDEJNDWLZJIQOQ-UHFFFAOYSA-N 2-methyl-6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC=CC=2)C=1COC1=CC=C(C(N)=O)C(C)=N1 LDEJNDWLZJIQOQ-UHFFFAOYSA-N 0.000 claims 1
- LRAROYWIRIHNSU-UHFFFAOYSA-N 3-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]oxetan-3-ol Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C1(O)COC1 LRAROYWIRIHNSU-UHFFFAOYSA-N 0.000 claims 1
- DGFQIJMEILPIEC-UHFFFAOYSA-N 5-methyl-3-phenyl-4-[(4-phenylmethoxypyridin-2-yl)oxymethyl]-1,2-oxazole Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=CC=1)=CC=1OCC1=CC=CC=C1 DGFQIJMEILPIEC-UHFFFAOYSA-N 0.000 claims 1
- AQJILTBAHDGOBA-UHFFFAOYSA-N 5-methyl-4-[(5-methylsulfanylpyridin-2-yl)oxymethyl]-3-phenyl-1,2-oxazole Chemical compound N1=CC(SC)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 AQJILTBAHDGOBA-UHFFFAOYSA-N 0.000 claims 1
- QVPHXHVPULGUAX-UHFFFAOYSA-N 5-methyl-4-[(5-methylsulfinylpyridin-2-yl)oxymethyl]-3-phenyl-1,2-oxazole Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(S(C)=O)C=N1 QVPHXHVPULGUAX-UHFFFAOYSA-N 0.000 claims 1
- NEJGMWRTNFBSRH-UHFFFAOYSA-N 5-methyl-4-[(6-methylpyridin-2-yl)oxymethyl]-3-phenyl-1,2-oxazole Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=CC(C)=N1 NEJGMWRTNFBSRH-UHFFFAOYSA-N 0.000 claims 1
- LVOQHEIDNJQOJB-UHFFFAOYSA-N 5-methyl-4-[[4-(1-methyl-3,6-dihydro-2h-pyridin-4-yl)pyridin-2-yl]oxymethyl]-3-phenyl-1,2-oxazole Chemical group C1N(C)CCC(C=2C=C(OCC=3C(=NOC=3C)C=3C=CC=CC=3)N=CC=2)=C1 LVOQHEIDNJQOJB-UHFFFAOYSA-N 0.000 claims 1
- XVKZCVMFSSJNJN-UHFFFAOYSA-N 5-methyl-4-[[5-(5-methyl-1h-1,2,4-triazol-3-yl)pyridin-2-yl]oxymethyl]-3-phenyl-1,2-oxazole Chemical compound N1C(C)=NN=C1C(C=N1)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 XVKZCVMFSSJNJN-UHFFFAOYSA-N 0.000 claims 1
- YJCANOFPNOMLGW-UHFFFAOYSA-N 5-methyl-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(C(=C1)C)=NC=C1C(=O)NC1CCOCC1 YJCANOFPNOMLGW-UHFFFAOYSA-N 0.000 claims 1
- GPVMOHOROTWYHX-UHFFFAOYSA-N 6-[(3-phenyl-1,2-oxazol-4-yl)methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=CON=C1C1=CC=CC=C1 GPVMOHOROTWYHX-UHFFFAOYSA-N 0.000 claims 1
- UZKYXZSNVTZQFC-UHFFFAOYSA-N 6-[(3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]-n-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCC(F)(F)F)=CC=C1OCC1=CON=C1C1=CC=CC=N1 UZKYXZSNVTZQFC-UHFFFAOYSA-N 0.000 claims 1
- AXSNSFLHODCXTA-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(1,1,1-trifluoropropan-2-yl)pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C(F)(F)F)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 AXSNSFLHODCXTA-UHFFFAOYSA-N 0.000 claims 1
- ZVODKUGKBFSMBB-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(1-methylpiperidin-4-yl)pyridine-3-carboxamide Chemical compound C1CN(C)CCC1NC(=O)C(C=N1)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 ZVODKUGKBFSMBB-UHFFFAOYSA-N 0.000 claims 1
- XTWCFVOMDOWSGI-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(1-methylpyrazol-3-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC=1C=CN(C)N=1 XTWCFVOMDOWSGI-UHFFFAOYSA-N 0.000 claims 1
- BFFSXKDARGTMMM-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(1-propan-2-ylpiperidin-4-yl)pyridine-3-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C(C=N1)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 BFFSXKDARGTMMM-UHFFFAOYSA-N 0.000 claims 1
- RKZJNKQLGZCYCR-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NCC(F)(F)F)C=N1 RKZJNKQLGZCYCR-UHFFFAOYSA-N 0.000 claims 1
- YUGQPTYNQHDELV-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(2-propan-2-yloxyethyl)pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCCOC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 YUGQPTYNQHDELV-UHFFFAOYSA-N 0.000 claims 1
- HGPSJWGUEKFTHM-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(3,3,3-trifluoro-2-hydroxypropyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NCC(O)C(F)(F)F)C=N1 HGPSJWGUEKFTHM-UHFFFAOYSA-N 0.000 claims 1
- WOXGCAVUJHNRNQ-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(3-phenylmethoxycyclobutyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC(C1)CC1OCC1=CC=CC=C1 WOXGCAVUJHNRNQ-UHFFFAOYSA-N 0.000 claims 1
- RESJIAYMMAZOQG-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(oxan-4-yl)-4-(trifluoromethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC(C(F)(F)F)=C1C(=O)NC1CCOCC1 RESJIAYMMAZOQG-UHFFFAOYSA-N 0.000 claims 1
- FFEJVVWWAAIHPR-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 FFEJVVWWAAIHPR-UHFFFAOYSA-N 0.000 claims 1
- TXBHFYXLZAIJFF-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-(oxolan-3-ylmethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NCC1CCOC1 TXBHFYXLZAIJFF-UHFFFAOYSA-N 0.000 claims 1
- YOBOTSCRSOCOSY-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-[1-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]piperidin-3-yl]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCCN(CC(=O)NCC(F)(F)F)C1 YOBOTSCRSOCOSY-UHFFFAOYSA-N 0.000 claims 1
- TXZSFSUQFBGDQY-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]-n-[2-(2-oxoimidazolidin-1-yl)ethyl]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NCCN1CCNC1=O TXZSFSUQFBGDQY-UHFFFAOYSA-N 0.000 claims 1
- CKGCXRPVZXISCP-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methylamino]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1CNC(N=C1)=CC=C1C(=O)NC1CCOCC1 CKGCXRPVZXISCP-UHFFFAOYSA-N 0.000 claims 1
- JNWXIPVJZKGMIM-UHFFFAOYSA-N 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methylamino]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1NCC1=C(C)ON=C1C1=CC=CC=C1 JNWXIPVJZKGMIM-UHFFFAOYSA-N 0.000 claims 1
- VEUCJUFCARGBRL-UHFFFAOYSA-N 6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]-n-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC=CC=2)C=1COC1=CC=C(C(=O)NCC(F)(F)F)C=N1 VEUCJUFCARGBRL-UHFFFAOYSA-N 0.000 claims 1
- RBJYKFLLCXRSGC-UHFFFAOYSA-N 6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 RBJYKFLLCXRSGC-UHFFFAOYSA-N 0.000 claims 1
- LCYPSUBRHKMZEF-UHFFFAOYSA-N 6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxylic acid Chemical compound CC=1ON=C(C=2N=CC=CC=2)C=1COC1=CC=C(C(O)=O)C=N1 LCYPSUBRHKMZEF-UHFFFAOYSA-N 0.000 claims 1
- WSUAOLLSBOXJQL-UHFFFAOYSA-N 6-[(5-methyl-3-pyridin-4-yl-1,2-oxazol-4-yl)methoxy]-n-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CN=CC=2)C=1COC1=CC=C(C(=O)NCC(F)(F)F)C=N1 WSUAOLLSBOXJQL-UHFFFAOYSA-N 0.000 claims 1
- BETYSPUHSNAASH-UHFFFAOYSA-N 6-[(5-methyl-3-pyridin-4-yl-1,2-oxazol-4-yl)methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CN=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 BETYSPUHSNAASH-UHFFFAOYSA-N 0.000 claims 1
- LSDZJHMGHXEJKA-UHFFFAOYSA-N 6-[(5-methyl-3-pyridin-4-yl-1,2-oxazol-4-yl)methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=NC=C1 LSDZJHMGHXEJKA-UHFFFAOYSA-N 0.000 claims 1
- FMCMZGOWUATYFJ-UHFFFAOYSA-N 6-[(5-methyl-3-pyrimidin-4-yl-1,2-oxazol-4-yl)methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=NC=N1 FMCMZGOWUATYFJ-UHFFFAOYSA-N 0.000 claims 1
- VPZNSIBKEAVWAN-UHFFFAOYSA-N 6-[[3-(2,3-difluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C(=C(F)C=CC=2)F)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 VPZNSIBKEAVWAN-UHFFFAOYSA-N 0.000 claims 1
- ICBHTYZSTULLFQ-UHFFFAOYSA-N 6-[[3-(2,3-difluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC(F)=C1F ICBHTYZSTULLFQ-UHFFFAOYSA-N 0.000 claims 1
- PPTRTFXKPPCZLJ-UHFFFAOYSA-N 6-[[3-(2,4-difluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C(=CC(F)=CC=2)F)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 PPTRTFXKPPCZLJ-UHFFFAOYSA-N 0.000 claims 1
- HBMHMSDLYGAVPU-UHFFFAOYSA-N 6-[[3-(2,4-difluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=C(F)C=C1F HBMHMSDLYGAVPU-UHFFFAOYSA-N 0.000 claims 1
- AGGCYLLVYLDGAX-UHFFFAOYSA-N 6-[[3-(2,5-difluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C(=CC=C(F)C=2)F)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 AGGCYLLVYLDGAX-UHFFFAOYSA-N 0.000 claims 1
- TWWYTHKALZPAEZ-UHFFFAOYSA-N 6-[[3-(2,5-difluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC(F)=CC=C1F TWWYTHKALZPAEZ-UHFFFAOYSA-N 0.000 claims 1
- YEUNIVCDHKRIML-UHFFFAOYSA-N 6-[[3-(2-fluoro-4-methylphenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=C(C)C=C1F YEUNIVCDHKRIML-UHFFFAOYSA-N 0.000 claims 1
- BHEAJYIVALSJBE-UHFFFAOYSA-N 6-[[3-(2-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C(=CC=CC=2)F)C=1COC1=CC=C(C(=O)NCC(F)(F)F)C=N1 BHEAJYIVALSJBE-UHFFFAOYSA-N 0.000 claims 1
- UFFWAFAEVCQASF-UHFFFAOYSA-N 6-[[3-(2-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(2,2,3,3,3-pentafluoropropyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C(=CC=CC=2)F)C=1COC1=CC=C(C(=O)NCC(F)(F)C(F)(F)F)C=N1 UFFWAFAEVCQASF-UHFFFAOYSA-N 0.000 claims 1
- KOMJBSYYTWBJBF-UHFFFAOYSA-N 6-[[3-(2-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C(=CC=CC=2)F)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 KOMJBSYYTWBJBF-UHFFFAOYSA-N 0.000 claims 1
- VFBJFRMXGQEJGN-UHFFFAOYSA-N 6-[[3-(3,4-difluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(F)C(F)=CC=2)C=1COC1=CC=C(C(=O)NCC(F)(F)F)C=N1 VFBJFRMXGQEJGN-UHFFFAOYSA-N 0.000 claims 1
- HNQXWRRZOSDWNQ-UHFFFAOYSA-N 6-[[3-(3,4-difluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(2-hydroxy-2-methylpropyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(F)C(F)=CC=2)C=1COC1=CC=C(C(=O)NCC(C)(C)O)C=N1 HNQXWRRZOSDWNQ-UHFFFAOYSA-N 0.000 claims 1
- UOUKYVXLCNTITF-UHFFFAOYSA-N 6-[[3-(3,4-difluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(3-hydroxy-2,2-dimethylpropyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(F)C(F)=CC=2)C=1COC1=CC=C(C(=O)NCC(C)(C)CO)C=N1 UOUKYVXLCNTITF-UHFFFAOYSA-N 0.000 claims 1
- OZPDTGUHKZLDCP-UHFFFAOYSA-N 6-[[3-(3,4-difluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(F)C(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 OZPDTGUHKZLDCP-UHFFFAOYSA-N 0.000 claims 1
- PNTZHPLHKAMZAC-UHFFFAOYSA-N 6-[[3-(3,4-difluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=C(F)C(F)=C1 PNTZHPLHKAMZAC-UHFFFAOYSA-N 0.000 claims 1
- YLMDCXWBSQNQOX-UHFFFAOYSA-N 6-[[3-(3-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(Cl)C=CC=2)C=1COC1=CC=C(C(=O)NCC(F)(F)F)C=N1 YLMDCXWBSQNQOX-UHFFFAOYSA-N 0.000 claims 1
- FPRNAZWYKWQQEU-UHFFFAOYSA-N 6-[[3-(3-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(cyclopropylmethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(Cl)C=CC=2)C=1COC(N=C1)=CC=C1C(=O)NCC1CC1 FPRNAZWYKWQQEU-UHFFFAOYSA-N 0.000 claims 1
- YMLQPPVUBPVWMN-UHFFFAOYSA-N 6-[[3-(3-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(Cl)C=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 YMLQPPVUBPVWMN-UHFFFAOYSA-N 0.000 claims 1
- VUQGXRGAYLGVPS-UHFFFAOYSA-N 6-[[3-(3-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-cyclopropylpyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(Cl)C=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CC1 VUQGXRGAYLGVPS-UHFFFAOYSA-N 0.000 claims 1
- VIFMHLABYKWPLL-UHFFFAOYSA-N 6-[[3-(3-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(F)C=CC=2)C=1COC1=CC=C(C(=O)NCC(F)(F)F)C=N1 VIFMHLABYKWPLL-UHFFFAOYSA-N 0.000 claims 1
- ZBYAJQNFTPTNFI-UHFFFAOYSA-N 6-[[3-(3-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(F)C=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 ZBYAJQNFTPTNFI-UHFFFAOYSA-N 0.000 claims 1
- FGPQYKHAVCWLAO-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-1,2-oxazol-4-yl]methoxy]-n-(2-hydroxyethyl)pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCCO)=CC=C1OCC1=CON=C1C1=CC=C(Cl)C=C1 FGPQYKHAVCWLAO-UHFFFAOYSA-N 0.000 claims 1
- BEVIABRWXULHKA-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-1,2-oxazol-4-yl]methoxy]-n-(2-hydroxypropyl)pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCC(O)C)=CC=C1OCC1=CON=C1C1=CC=C(Cl)C=C1 BEVIABRWXULHKA-UHFFFAOYSA-N 0.000 claims 1
- WSTGDIKDWSHKTK-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-1,2-oxazol-4-yl]methoxy]-n-(3-hydroxy-2,2-dimethylpropyl)pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCC(C)(CO)C)=CC=C1OCC1=CON=C1C1=CC=C(Cl)C=C1 WSTGDIKDWSHKTK-UHFFFAOYSA-N 0.000 claims 1
- FESJPTYXCWUOQM-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-1,2-oxazol-4-yl]methoxy]-n-(3-hydroxypropyl)pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCCCO)=CC=C1OCC1=CON=C1C1=CC=C(Cl)C=C1 FESJPTYXCWUOQM-UHFFFAOYSA-N 0.000 claims 1
- IGXMXTUDKDNXBK-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound C1=CC(Cl)=CC=C1C1=NOC=C1COC1=CC=C(C(=O)NC2CCOCC2)C=N1 IGXMXTUDKDNXBK-UHFFFAOYSA-N 0.000 claims 1
- PIAFQDBMNFVESW-NSHDSACASA-N 6-[[3-(4-chlorophenyl)-1,2-oxazol-4-yl]methoxy]-n-[(2s)-1,1,1-trifluoropropan-2-yl]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)N[C@@H](C)C(F)(F)F)=CC=C1OCC1=CON=C1C1=CC=C(Cl)C=C1 PIAFQDBMNFVESW-NSHDSACASA-N 0.000 claims 1
- OXGMVOXUNNXRFM-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-1,2-oxazol-4-yl]methoxy]-n-cyclopropylpyridine-3-carboxamide Chemical compound C1=CC(Cl)=CC=C1C1=NOC=C1COC1=CC=C(C(=O)NC2CC2)C=N1 OXGMVOXUNNXRFM-UHFFFAOYSA-N 0.000 claims 1
- RSYYOIOLHPGIQZ-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-1,2-oxazol-4-yl]methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=CON=C1C1=CC=C(Cl)C=C1 RSYYOIOLHPGIQZ-UHFFFAOYSA-N 0.000 claims 1
- OAJFXLONALDQMM-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(1-hydroxy-2-methylpropan-2-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(Cl)=CC=2)C=1COC1=CC=C(C(=O)NC(C)(C)CO)C=N1 OAJFXLONALDQMM-UHFFFAOYSA-N 0.000 claims 1
- HDNWJKMMTZAYSO-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(1-methylpyrazol-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(Cl)=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC=1C=NN(C)C=1 HDNWJKMMTZAYSO-UHFFFAOYSA-N 0.000 claims 1
- YJMBMXMMKOPBLD-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(Cl)=CC=2)C=1COC1=CC=C(C(=O)NCC(F)(F)F)C=N1 YJMBMXMMKOPBLD-UHFFFAOYSA-N 0.000 claims 1
- MBRABNLWKANAQU-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(cyclopropylmethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(Cl)=CC=2)C=1COC(N=C1)=CC=C1C(=O)NCC1CC1 MBRABNLWKANAQU-UHFFFAOYSA-N 0.000 claims 1
- BZWIJCMFIDASAD-RTBURBONSA-N 6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-[(1r,2r)-2-hydroxycyclopentyl]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(Cl)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N[C@@H]1CCC[C@H]1O BZWIJCMFIDASAD-RTBURBONSA-N 0.000 claims 1
- BZWIJCMFIDASAD-OALUTQOASA-N 6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-[(1s,2s)-2-hydroxycyclopentyl]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(Cl)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N[C@H]1CCC[C@@H]1O BZWIJCMFIDASAD-OALUTQOASA-N 0.000 claims 1
- DCEHNNNBACRVLV-GFCCVEGCSA-N 6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-[(2r)-1-hydroxypropan-2-yl]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)N[C@@H](CO)C)=CC=C1OCC1=C(C)ON=C1C1=CC=C(Cl)C=C1 DCEHNNNBACRVLV-GFCCVEGCSA-N 0.000 claims 1
- DCEHNNNBACRVLV-LBPRGKRZSA-N 6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-[(2s)-1-hydroxypropan-2-yl]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)N[C@H](CO)C)=CC=C1OCC1=C(C)ON=C1C1=CC=C(Cl)C=C1 DCEHNNNBACRVLV-LBPRGKRZSA-N 0.000 claims 1
- DTNAXROICAPJTO-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-cyclopropylpyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(Cl)=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CC1 DTNAXROICAPJTO-UHFFFAOYSA-N 0.000 claims 1
- QXXHRDARSLCBQO-UHFFFAOYSA-N 6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=C(Cl)C=C1 QXXHRDARSLCBQO-UHFFFAOYSA-N 0.000 claims 1
- KGBFNMXVPFHTFK-UHFFFAOYSA-N 6-[[3-(4-fluorophenyl)-1,2-oxazol-4-yl]methoxy]-n-(1-hydroxypropan-2-yl)pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(CO)C)=CC=C1OCC1=CON=C1C1=CC=C(F)C=C1 KGBFNMXVPFHTFK-UHFFFAOYSA-N 0.000 claims 1
- KGBFNMXVPFHTFK-GFCCVEGCSA-N 6-[[3-(4-fluorophenyl)-1,2-oxazol-4-yl]methoxy]-n-[(2r)-1-hydroxypropan-2-yl]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)N[C@@H](CO)C)=CC=C1OCC1=CON=C1C1=CC=C(F)C=C1 KGBFNMXVPFHTFK-GFCCVEGCSA-N 0.000 claims 1
- BCQVXCCWNGHILE-UHFFFAOYSA-N 6-[[3-(4-fluorophenyl)-1,2-oxazol-4-yl]methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=CON=C1C1=CC=C(F)C=C1 BCQVXCCWNGHILE-UHFFFAOYSA-N 0.000 claims 1
- VXSODAOHMBAYGE-UHFFFAOYSA-N 6-[[3-(4-fluorophenyl)-5-(trifluoromethyl)-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1C1=NOC(C(F)(F)F)=C1COC1=CC=C(C(=O)NC2CCOCC2)C=N1 VXSODAOHMBAYGE-UHFFFAOYSA-N 0.000 claims 1
- SYTGZUMODGDAOP-UHFFFAOYSA-N 6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC1=CC=C(C(=O)NCC(F)(F)F)C=N1 SYTGZUMODGDAOP-UHFFFAOYSA-N 0.000 claims 1
- RKAXYUZQFLSKQW-UHFFFAOYSA-N 6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 RKAXYUZQFLSKQW-UHFFFAOYSA-N 0.000 claims 1
- SMSDGZOOYOAPBR-UHFFFAOYSA-N 6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=C(F)C=C1 SMSDGZOOYOAPBR-UHFFFAOYSA-N 0.000 claims 1
- WUOUFZKVGVKOMH-UHFFFAOYSA-N 6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methylamino]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1CNC(N=C1)=CC=C1C(=O)NC1CCOCC1 WUOUFZKVGVKOMH-UHFFFAOYSA-N 0.000 claims 1
- KKXFVUZLEPUQCF-UHFFFAOYSA-N 6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methylamino]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1NCC1=C(C)ON=C1C1=CC=C(F)C=C1 KKXFVUZLEPUQCF-UHFFFAOYSA-N 0.000 claims 1
- RIULYWRYOHZZHB-UHFFFAOYSA-N 6-[[3-(5-chloropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]-2-(1-hydroxy-2-methylpropan-2-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC(Cl)=CC=2)C=1COC1=CC=C(C(N)=O)C(C(C)(C)CO)=N1 RIULYWRYOHZZHB-UHFFFAOYSA-N 0.000 claims 1
- VGJBEIVLZDSMEB-UHFFFAOYSA-N 6-[[3-(5-chloropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]-2-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC(Cl)=CC=2)C=1COC1=CC=C(C(N)=O)C(CC(F)(F)F)=N1 VGJBEIVLZDSMEB-UHFFFAOYSA-N 0.000 claims 1
- FBXLHXXXWYJZDD-UHFFFAOYSA-N 6-[[3-(5-chloropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]-2-(2-hydroxyethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC(Cl)=CC=2)C=1COC1=CC=C(C(N)=O)C(CCO)=N1 FBXLHXXXWYJZDD-UHFFFAOYSA-N 0.000 claims 1
- RKORDJSYPFWEQC-UHFFFAOYSA-N 6-[[3-(5-chloropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]-2-(cyclopropylmethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC(Cl)=CC=2)C=1COC(N=1)=CC=C(C(N)=O)C=1CC1CC1 RKORDJSYPFWEQC-UHFFFAOYSA-N 0.000 claims 1
- VCOCKLZFBDPCJO-UHFFFAOYSA-N 6-[[3-(5-chloropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]-2-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC(Cl)=CC=2)C=1COC(N=1)=CC=C(C(N)=O)C=1C1CCOCC1 VCOCKLZFBDPCJO-UHFFFAOYSA-N 0.000 claims 1
- UROLFLUBHQHCOI-UHFFFAOYSA-N 6-[[3-(5-chloropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridine-3-carboxylic acid Chemical compound CC=1ON=C(C=2N=CC(Cl)=CC=2)C=1COC1=CC=C(C(O)=O)C=N1 UROLFLUBHQHCOI-UHFFFAOYSA-N 0.000 claims 1
- KMIBELYXOHGPSW-UHFFFAOYSA-N 6-[[3-(5-fluoropyridin-2-yl)-1,2-oxazol-4-yl]methoxy]-2-(oxan-4-yl)pyridine-3-carboxamide Chemical compound N1=C(C2CCOCC2)C(C(=O)N)=CC=C1OCC1=CON=C1C1=CC=C(F)C=N1 KMIBELYXOHGPSW-UHFFFAOYSA-N 0.000 claims 1
- INZADJNYFNXGEG-UHFFFAOYSA-N 6-[[3-(5-fluoropyridin-2-yl)-1,2-oxazol-4-yl]methoxy]-2-propan-2-ylpyridine-3-carboxamide Chemical compound C1=C(C(N)=O)C(C(C)C)=NC(OCC=2C(=NOC=2)C=2N=CC(F)=CC=2)=C1 INZADJNYFNXGEG-UHFFFAOYSA-N 0.000 claims 1
- JMWUKFAZOLVXPL-UHFFFAOYSA-N 6-[[3-(5-fluoropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]-2-(2-hydroxyethyl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC(F)=CC=2)C=1COC1=CC=C(C(N)=O)C(CCO)=N1 JMWUKFAZOLVXPL-UHFFFAOYSA-N 0.000 claims 1
- OZPFCPRINMNIKU-UHFFFAOYSA-N 6-[[3-(5-fluoropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]-2-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC(F)=CC=2)C=1COC(N=1)=CC=C(C(N)=O)C=1C1CCOCC1 OZPFCPRINMNIKU-UHFFFAOYSA-N 0.000 claims 1
- VFJRMKQHYYEJHL-UHFFFAOYSA-N 6-[[3-(5-fluoropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]-2-propan-2-ylpyridine-3-carboxamide Chemical compound C1=C(C(N)=O)C(C(C)C)=NC(OCC=2C(=NOC=2C)C=2N=CC(F)=CC=2)=C1 VFJRMKQHYYEJHL-UHFFFAOYSA-N 0.000 claims 1
- MDHWOWNOCXTAQE-UHFFFAOYSA-N 6-[[3-(5-fluoropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridine-3-carboxylic acid Chemical compound CC=1ON=C(C=2N=CC(F)=CC=2)C=1COC1=CC=C(C(O)=O)C=N1 MDHWOWNOCXTAQE-UHFFFAOYSA-N 0.000 claims 1
- VXRVLSRQRCRDCK-UHFFFAOYSA-N 6-[[5-methyl-3-(3-methylphenyl)-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(C)C=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 VXRVLSRQRCRDCK-UHFFFAOYSA-N 0.000 claims 1
- CZDSZLZSVCCXGV-UHFFFAOYSA-N 6-[[5-methyl-3-(3-methylphenyl)-1,2-oxazol-4-yl]methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC(C)=C1 CZDSZLZSVCCXGV-UHFFFAOYSA-N 0.000 claims 1
- VCAOZNYTIATHLZ-UHFFFAOYSA-N 6-[[5-methyl-3-(4-methylphenyl)-1,2-oxazol-4-yl]methoxy]-n-(oxan-4-yl)pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(C)=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCOCC1 VCAOZNYTIATHLZ-UHFFFAOYSA-N 0.000 claims 1
- KOURMMJUNZQWKS-UHFFFAOYSA-N 6-[[5-methyl-3-(4-methylphenyl)-1,2-oxazol-4-yl]methoxy]-n-propan-2-ylpyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=C(C)C=C1 KOURMMJUNZQWKS-UHFFFAOYSA-N 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- QGDVBORCHDZMAL-UHFFFAOYSA-N [6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridin-3-yl]-(1,3-thiazolidin-3-yl)methanone Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCSC1 QGDVBORCHDZMAL-UHFFFAOYSA-N 0.000 claims 1
- HTERIYKSTDJXFS-UHFFFAOYSA-N [6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridin-3-yl]-(2-methylpyrrolidin-1-yl)methanone Chemical compound CC1CCCN1C(=O)C(C=N1)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 HTERIYKSTDJXFS-UHFFFAOYSA-N 0.000 claims 1
- RPFYRYJYWKHVAR-UHFFFAOYSA-N [6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridin-3-yl]-pyrrolidin-1-ylmethanone Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCCC1 RPFYRYJYWKHVAR-UHFFFAOYSA-N 0.000 claims 1
- VQORXIASXUHNLL-UHFFFAOYSA-N [6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridin-3-yl]-morpholin-4-ylmethanone Chemical compound CC=1ON=C(C=2N=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCOCC1 VQORXIASXUHNLL-UHFFFAOYSA-N 0.000 claims 1
- LGPNUUFCZUGJOR-UHFFFAOYSA-N [6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridin-3-yl]-thiomorpholin-4-ylmethanone Chemical compound CC=1ON=C(C=2N=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCSCC1 LGPNUUFCZUGJOR-UHFFFAOYSA-N 0.000 claims 1
- DAJRUXSXBYSSKM-UHFFFAOYSA-N [6-[(5-methyl-3-pyrimidin-4-yl-1,2-oxazol-4-yl)methoxy]pyridin-3-yl]-morpholin-4-ylmethanone Chemical compound CC=1ON=C(C=2N=CN=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCOCC1 DAJRUXSXBYSSKM-UHFFFAOYSA-N 0.000 claims 1
- LSKVQEOEQWSFGM-UHFFFAOYSA-N [6-[(5-methyl-3-pyrimidin-4-yl-1,2-oxazol-4-yl)methoxy]pyridin-3-yl]-thiomorpholin-4-ylmethanone Chemical compound CC=1ON=C(C=2N=CN=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCSCC1 LSKVQEOEQWSFGM-UHFFFAOYSA-N 0.000 claims 1
- ADAMMRCTMLWZRL-UHFFFAOYSA-N [6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]-(1,1-dioxo-1,4-thiazinan-4-yl)methanone Chemical compound CC=1ON=C(C=2C=CC(Cl)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 ADAMMRCTMLWZRL-UHFFFAOYSA-N 0.000 claims 1
- BVFJTUGLGFIJID-UHFFFAOYSA-N [6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]-morpholin-4-ylmethanone Chemical compound CC=1ON=C(C=2C=CC(Cl)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCOCC1 BVFJTUGLGFIJID-UHFFFAOYSA-N 0.000 claims 1
- KEJSHHZFSWNGBI-UHFFFAOYSA-N [6-[[3-(4-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]-thiomorpholin-4-ylmethanone Chemical compound CC=1ON=C(C=2C=CC(Cl)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCSCC1 KEJSHHZFSWNGBI-UHFFFAOYSA-N 0.000 claims 1
- CBSKGIYMMMTKHK-UHFFFAOYSA-N [6-[[3-(5-chloropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]-morpholin-4-ylmethanone Chemical compound CC=1ON=C(C=2N=CC(Cl)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCOCC1 CBSKGIYMMMTKHK-UHFFFAOYSA-N 0.000 claims 1
- JGAPXKNSMVXLBA-UHFFFAOYSA-N [6-[[3-(5-chloropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]-thiomorpholin-4-ylmethanone Chemical compound CC=1ON=C(C=2N=CC(Cl)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCSCC1 JGAPXKNSMVXLBA-UHFFFAOYSA-N 0.000 claims 1
- 238000007112 amidation reaction Methods 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- SBAPISQMMJYQLI-UHFFFAOYSA-N azetidin-1-yl-[6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCC1 SBAPISQMMJYQLI-UHFFFAOYSA-N 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 230000001149 cognitive effect Effects 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- AJPICTKFMAOCMJ-QHCPKHFHSA-N methyl (2s)-2-[[6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carbonyl]amino]-3-phenylpropanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)C=1C=NC(OCC=2C(=NOC=2C)C=2C=CC=CC=2)=CC=1)C1=CC=CC=C1 AJPICTKFMAOCMJ-QHCPKHFHSA-N 0.000 claims 1
- BXGSBHHIBBVDRP-UHFFFAOYSA-N methyl 6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxylate Chemical compound N1=CC(C(=O)OC)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=N1 BXGSBHHIBBVDRP-UHFFFAOYSA-N 0.000 claims 1
- NRURXSQJQOCKDU-UHFFFAOYSA-N methyl 6-[(5-methyl-3-pyrimidin-4-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxylate Chemical compound N1=CC(C(=O)OC)=CC=C1OCC1=C(C)ON=C1C1=CC=NC=N1 NRURXSQJQOCKDU-UHFFFAOYSA-N 0.000 claims 1
- UIESIDBIPPSKRK-UHFFFAOYSA-N methyl 6-[[3-(5-chloropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridine-3-carboxylate Chemical compound N1=CC(C(=O)OC)=CC=C1OCC1=C(C)ON=C1C1=CC=C(Cl)C=N1 UIESIDBIPPSKRK-UHFFFAOYSA-N 0.000 claims 1
- YFFSQJZOEORGNJ-UHFFFAOYSA-N methyl 6-[[3-(5-fluoropyridin-2-yl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridine-3-carboxylate Chemical compound N1=CC(C(=O)OC)=CC=C1OCC1=C(C)ON=C1C1=CC=C(F)C=N1 YFFSQJZOEORGNJ-UHFFFAOYSA-N 0.000 claims 1
- RMEDXVIWDFLGES-UHFFFAOYSA-N methyl 6-chloropyridine-3-carboxylate Chemical compound COC(=O)C1=CC=C(Cl)N=C1 RMEDXVIWDFLGES-UHFFFAOYSA-N 0.000 claims 1
- ZLFKJACVTUOGRN-UHFFFAOYSA-N n-(1,1-dioxothiolan-3-yl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCS(=O)(=O)C1 ZLFKJACVTUOGRN-UHFFFAOYSA-N 0.000 claims 1
- QIBAVWGAZAWRRY-UHFFFAOYSA-N n-(1,3-dihydroxypropan-2-yl)-6-[[3-(4-fluorophenyl)-1,2-oxazol-4-yl]methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(CO)CO)=CC=C1OCC1=CON=C1C1=CC=C(F)C=C1 QIBAVWGAZAWRRY-UHFFFAOYSA-N 0.000 claims 1
- IQSQKAUSHODDNU-UHFFFAOYSA-N n-(1-ethylpiperidin-3-yl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound C1N(CC)CCCC1NC(=O)C(C=N1)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 IQSQKAUSHODDNU-UHFFFAOYSA-N 0.000 claims 1
- MPULOCVGOZDGRW-UHFFFAOYSA-N n-(1-ethylpiperidin-4-yl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound C1CN(CC)CCC1NC(=O)C(C=N1)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 MPULOCVGOZDGRW-UHFFFAOYSA-N 0.000 claims 1
- IXNNHLJSIRKAMO-UHFFFAOYSA-N n-(1-hydroxy-2-methylpropan-2-yl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NC(C)(C)CO)C=N1 IXNNHLJSIRKAMO-UHFFFAOYSA-N 0.000 claims 1
- WHAGLYKNWUROAY-UHFFFAOYSA-N n-(1-hydroxy-2-methylpropan-2-yl)-6-[(5-methyl-3-pyrimidin-4-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CN=CC=2)C=1COC1=CC=C(C(=O)NC(C)(C)CO)C=N1 WHAGLYKNWUROAY-UHFFFAOYSA-N 0.000 claims 1
- YAHZRBSLBAJZOS-UHFFFAOYSA-N n-(1-hydroxypropan-2-yl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(CO)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 YAHZRBSLBAJZOS-UHFFFAOYSA-N 0.000 claims 1
- KSAAGOBJZYTCDG-UHFFFAOYSA-N n-(1-methylcyclopropyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1(C)CC1 KSAAGOBJZYTCDG-UHFFFAOYSA-N 0.000 claims 1
- QTJROJPHQVVSJN-UHFFFAOYSA-N n-(2,2-difluoroethyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NCC(F)F)C=N1 QTJROJPHQVVSJN-UHFFFAOYSA-N 0.000 claims 1
- DODBQOYAIRZVMS-UHFFFAOYSA-N n-(2-acetamidoethyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCCNC(=O)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 DODBQOYAIRZVMS-UHFFFAOYSA-N 0.000 claims 1
- BEMBLBKVLJVNBD-UHFFFAOYSA-N n-(2-acetamidoethyl)-6-[[3-(4-chlorophenyl)-1,2-oxazol-4-yl]methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCCNC(=O)C)=CC=C1OCC1=CON=C1C1=CC=C(Cl)C=C1 BEMBLBKVLJVNBD-UHFFFAOYSA-N 0.000 claims 1
- OQUMKNQHNICOQF-UHFFFAOYSA-N n-(2-acetamidoethyl)-6-[[3-(4-fluorophenyl)-1,2-oxazol-4-yl]methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCCNC(=O)C)=CC=C1OCC1=CON=C1C1=CC=C(F)C=C1 OQUMKNQHNICOQF-UHFFFAOYSA-N 0.000 claims 1
- XNZOOJHXUQOXMW-UHFFFAOYSA-N n-(2-ethylbutyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCC(CC)CC)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 XNZOOJHXUQOXMW-UHFFFAOYSA-N 0.000 claims 1
- LDKHAFPYLPDPEG-UHFFFAOYSA-N n-(2-fluoroethyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NCCF)C=N1 LDKHAFPYLPDPEG-UHFFFAOYSA-N 0.000 claims 1
- OLABBJCYYJUPKT-UHFFFAOYSA-N n-(2-hydroxy-2-methylpropyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NCC(C)(C)O)C=N1 OLABBJCYYJUPKT-UHFFFAOYSA-N 0.000 claims 1
- UDGOBDSFWBJVTE-UHFFFAOYSA-N n-(2-hydroxycyclopentyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCCC1O UDGOBDSFWBJVTE-UHFFFAOYSA-N 0.000 claims 1
- AHUSPBKZGQZHQB-UHFFFAOYSA-N n-(2-hydroxyethyl)-6-[(3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCCO)=CC=C1OCC1=CON=C1C1=CC=CC=N1 AHUSPBKZGQZHQB-UHFFFAOYSA-N 0.000 claims 1
- CXLGRDWQPOPFMB-UHFFFAOYSA-N n-(2-hydroxyethyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NCCO)C=N1 CXLGRDWQPOPFMB-UHFFFAOYSA-N 0.000 claims 1
- FSWTYQZVIWUETC-UHFFFAOYSA-N n-(2-hydroxyethyl)-6-[(5-methyl-3-pyrimidin-4-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CN=CC=2)C=1COC1=CC=C(C(=O)NCCO)C=N1 FSWTYQZVIWUETC-UHFFFAOYSA-N 0.000 claims 1
- BKFHVPJRLKKUSD-UHFFFAOYSA-N n-(3-hydroxy-2,2-dimethylpropyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NCC(C)(C)CO)C=N1 BKFHVPJRLKKUSD-UHFFFAOYSA-N 0.000 claims 1
- XGRYPRZRAAMMKM-UHFFFAOYSA-N n-(3-hydroxybutyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCCC(O)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 XGRYPRZRAAMMKM-UHFFFAOYSA-N 0.000 claims 1
- DRFVSJCRDHQNKN-UHFFFAOYSA-N n-(3-hydroxypropyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NCCCO)C=N1 DRFVSJCRDHQNKN-UHFFFAOYSA-N 0.000 claims 1
- FSHWYSWVXJHBAE-UHFFFAOYSA-N n-(3-methoxypropyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCCCOC)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 FSHWYSWVXJHBAE-UHFFFAOYSA-N 0.000 claims 1
- WDZSJJQVQXUBKN-UHFFFAOYSA-N n-(3-methyloxetan-3-yl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1(C)COC1 WDZSJJQVQXUBKN-UHFFFAOYSA-N 0.000 claims 1
- ACHBHNFIMNZOOZ-UHFFFAOYSA-N n-(4-hydroxybutyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NCCCCO)C=N1 ACHBHNFIMNZOOZ-UHFFFAOYSA-N 0.000 claims 1
- RPLUYUVVTJOMJF-UHFFFAOYSA-N n-(5-hydroxypentyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NCCCCCO)C=N1 RPLUYUVVTJOMJF-UHFFFAOYSA-N 0.000 claims 1
- FZKLAHBCRAGPPC-UHFFFAOYSA-N n-(cyclopropylmethyl)-6-[(3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound C=1C=C(OCC=2C(=NOC=2)C=2N=CC=CC=2)N=CC=1C(=O)NCC1CC1 FZKLAHBCRAGPPC-UHFFFAOYSA-N 0.000 claims 1
- RYZYJNRVHPFAEX-UHFFFAOYSA-N n-(cyclopropylmethyl)-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NCC1CC1 RYZYJNRVHPFAEX-UHFFFAOYSA-N 0.000 claims 1
- OIESNVCCCLZHJE-UHFFFAOYSA-N n-(cyclopropylmethyl)-6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NCC1CC1 OIESNVCCCLZHJE-UHFFFAOYSA-N 0.000 claims 1
- YMNBLKSITVXHKH-UHFFFAOYSA-N n-(cyclopropylmethyl)-6-[[3-(3-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=C(F)C=CC=2)C=1COC(N=C1)=CC=C1C(=O)NCC1CC1 YMNBLKSITVXHKH-UHFFFAOYSA-N 0.000 claims 1
- KTRQNCVZFVGSQC-UHFFFAOYSA-N n-(cyclopropylmethyl)-6-[[3-(4-fluorophenyl)-1,2-oxazol-4-yl]methoxy]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1C1=NOC=C1COC1=CC=C(C(=O)NCC2CC2)C=N1 KTRQNCVZFVGSQC-UHFFFAOYSA-N 0.000 claims 1
- TVGGDSDCPKZAMT-UHFFFAOYSA-N n-(cyclopropylmethyl)-6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)NCC1CC1 TVGGDSDCPKZAMT-UHFFFAOYSA-N 0.000 claims 1
- UTAOHGBTBQAGJG-UHFFFAOYSA-N n-(cyclopropylmethyl)-6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methylamino]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1CNC(N=C1)=CC=C1C(=O)NCC1CC1 UTAOHGBTBQAGJG-UHFFFAOYSA-N 0.000 claims 1
- DMZWWXHTJHTRRH-UHFFFAOYSA-N n-(oxan-4-yl)-6-[(3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound C=1C=C(OCC=2C(=NOC=2)C=2C=CC=CC=2)N=CC=1C(=O)NC1CCOCC1 DMZWWXHTJHTRRH-UHFFFAOYSA-N 0.000 claims 1
- PHMFFBVIQSRMJR-UHFFFAOYSA-N n-(oxan-4-yl)-6-[(3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound C=1C=C(OCC=2C(=NOC=2)C=2N=CC=CC=2)N=CC=1C(=O)NC1CCOCC1 PHMFFBVIQSRMJR-UHFFFAOYSA-N 0.000 claims 1
- DERLWJKVSFUZRZ-UHFFFAOYSA-N n-[(1-hydroxycyclopropyl)methyl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NCC1(O)CC1 DERLWJKVSFUZRZ-UHFFFAOYSA-N 0.000 claims 1
- ACZAFEQDAPBKEG-WOJBJXKFSA-N n-[(1r,2r)-2-hydroxycyclohexyl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)N[C@@H]1CCCC[C@H]1O ACZAFEQDAPBKEG-WOJBJXKFSA-N 0.000 claims 1
- UDGOBDSFWBJVTE-MOPGFXCFSA-N n-[(1r,2s)-2-hydroxycyclopentyl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)N[C@@H]1CCC[C@@H]1O UDGOBDSFWBJVTE-MOPGFXCFSA-N 0.000 claims 1
- ACZAFEQDAPBKEG-PMACEKPBSA-N n-[(1s,2s)-2-hydroxycyclohexyl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)N[C@H]1CCCC[C@@H]1O ACZAFEQDAPBKEG-PMACEKPBSA-N 0.000 claims 1
- IHBDJLQRENXTKF-QGZVFWFLSA-N n-[(2r)-1-hydroxybutan-2-yl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)N[C@@H](CO)CC)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 IHBDJLQRENXTKF-QGZVFWFLSA-N 0.000 claims 1
- YAHZRBSLBAJZOS-CYBMUJFWSA-N n-[(2r)-1-hydroxypropan-2-yl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)N[C@@H](CO)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 YAHZRBSLBAJZOS-CYBMUJFWSA-N 0.000 claims 1
- ILXKERGLPHVXND-LJQANCHMSA-N n-[(2s)-1-hydroxy-3-methylbutan-2-yl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)N[C@H](CO)C(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 ILXKERGLPHVXND-LJQANCHMSA-N 0.000 claims 1
- ZZPFPKMHVPSPDP-IBGZPJMESA-N n-[(2s)-1-hydroxy-4-methylpentan-2-yl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)N[C@H](CO)CC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 ZZPFPKMHVPSPDP-IBGZPJMESA-N 0.000 claims 1
- IHBDJLQRENXTKF-KRWDZBQOSA-N n-[(2s)-1-hydroxybutan-2-yl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)N[C@H](CO)CC)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 IHBDJLQRENXTKF-KRWDZBQOSA-N 0.000 claims 1
- YAHZRBSLBAJZOS-ZDUSSCGKSA-N n-[(2s)-1-hydroxypropan-2-yl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)N[C@H](CO)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 YAHZRBSLBAJZOS-ZDUSSCGKSA-N 0.000 claims 1
- RLDMJJVJPFZHJC-UHFFFAOYSA-N n-[(3-methyl-6-oxo-1h-pyridazin-5-yl)methyl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NCC1=CC(C)=NNC1=O RLDMJJVJPFZHJC-UHFFFAOYSA-N 0.000 claims 1
- BGBNSGJZJHYDLU-UHFFFAOYSA-N n-[(4-cyano-1,3-thiazol-2-yl)methyl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NCC1=NC(C#N)=CS1 BGBNSGJZJHYDLU-UHFFFAOYSA-N 0.000 claims 1
- XTVWOUDBGUNVLU-UHFFFAOYSA-N n-[1-[2-(2-hydroxyethylamino)-2-oxoethyl]piperidin-3-yl]-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCCN(CC(=O)NCCO)C1 XTVWOUDBGUNVLU-UHFFFAOYSA-N 0.000 claims 1
- RHARVCJGBVKURN-UHFFFAOYSA-N n-butylsulfonyl-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NS(=O)(=O)CCCC)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 RHARVCJGBVKURN-UHFFFAOYSA-N 0.000 claims 1
- RFWHUQCYLLPWHN-UHFFFAOYSA-N n-cyclobutyl-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCC1 RFWHUQCYLLPWHN-UHFFFAOYSA-N 0.000 claims 1
- XYWPLMRGWADGHX-UHFFFAOYSA-N n-cyclopentyl-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CCCC1 XYWPLMRGWADGHX-UHFFFAOYSA-N 0.000 claims 1
- QCMGTWAXBGKYPQ-UHFFFAOYSA-N n-cyclopropyl-6-[(3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound C=1C=C(OCC=2C(=NOC=2)C=2N=CC=CC=2)N=CC=1C(=O)NC1CC1 QCMGTWAXBGKYPQ-UHFFFAOYSA-N 0.000 claims 1
- VQGDWRPRXJFPDW-UHFFFAOYSA-N n-cyclopropyl-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CC1 VQGDWRPRXJFPDW-UHFFFAOYSA-N 0.000 claims 1
- RFQGMOMKALZEOS-UHFFFAOYSA-N n-cyclopropyl-6-[(5-methyl-3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CC1 RFQGMOMKALZEOS-UHFFFAOYSA-N 0.000 claims 1
- BGGSFRYHUXBRMW-UHFFFAOYSA-N n-cyclopropyl-6-[(5-methyl-3-pyrimidin-4-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound CC=1ON=C(C=2N=CN=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CC1 BGGSFRYHUXBRMW-UHFFFAOYSA-N 0.000 claims 1
- BXKBSYPXFFPMHD-UHFFFAOYSA-N n-cyclopropyl-6-[[3-(4-fluorophenyl)-1,2-oxazol-4-yl]methoxy]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1C1=NOC=C1COC1=CC=C(C(=O)NC2CC2)C=N1 BXKBSYPXFFPMHD-UHFFFAOYSA-N 0.000 claims 1
- ZRNZCYYJCCIJJN-UHFFFAOYSA-N n-cyclopropylsulfonyl-n-methyl-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound C1CC1S(=O)(=O)N(C)C(=O)C(C=N1)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 ZRNZCYYJCCIJJN-UHFFFAOYSA-N 0.000 claims 1
- MBXGVZZWGPSLLN-UHFFFAOYSA-N n-ethyl-6-[(3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCC)=CC=C1OCC1=CON=C1C1=CC=CC=N1 MBXGVZZWGPSLLN-UHFFFAOYSA-N 0.000 claims 1
- MNKULLKSVZZNEF-UHFFFAOYSA-N n-ethyl-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCC)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 MNKULLKSVZZNEF-UHFFFAOYSA-N 0.000 claims 1
- CJWUHHXGASLLJM-UHFFFAOYSA-N n-ethyl-6-[(5-methyl-3-pyrimidin-4-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NCC)=CC=C1OCC1=C(C)ON=C1C1=CC=NC=N1 CJWUHHXGASLLJM-UHFFFAOYSA-N 0.000 claims 1
- TXJLIIKLVOSACS-UHFFFAOYSA-N n-methyl-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 TXJLIIKLVOSACS-UHFFFAOYSA-N 0.000 claims 1
- UNTJFEAIYBLWEL-UHFFFAOYSA-N n-propan-2-yl-6-[(3-pyridin-2-yl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxamide Chemical compound N1=CC(C(=O)NC(C)C)=CC=C1OCC1=CON=C1C1=CC=CC=N1 UNTJFEAIYBLWEL-UHFFFAOYSA-N 0.000 claims 1
- ALVAVNDRCKJBPX-UHFFFAOYSA-N propan-2-yl 6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carboxylate Chemical compound N1=CC(C(=O)OC(C)C)=CC=C1OCC1=C(C)ON=C1C1=CC=CC=C1 ALVAVNDRCKJBPX-UHFFFAOYSA-N 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- YTIFGMISGOJRBO-UHFFFAOYSA-N tert-butyl 3-[[6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carbonyl]amino]azetidine-1-carboxylate Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC(N=C1)=CC=C1C(=O)NC1CN(C(=O)OC(C)(C)C)C1 YTIFGMISGOJRBO-UHFFFAOYSA-N 0.000 claims 1
- QCZDZJMNUSTUDB-UHFFFAOYSA-N tert-butyl 3-[[6-[[3-(4-chlorophenyl)-1,2-oxazol-4-yl]methoxy]pyridine-3-carbonyl]amino]azetidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC1NC(=O)C(C=N1)=CC=C1OCC1=CON=C1C1=CC=C(Cl)C=C1 QCZDZJMNUSTUDB-UHFFFAOYSA-N 0.000 claims 1
- VGNVRWVRGFTTOF-UHFFFAOYSA-N tert-butyl n-[2-[[6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)methoxy]pyridine-3-carbonyl]amino]ethyl]carbamate Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1COC1=CC=C(C(=O)NCCNC(=O)OC(C)(C)C)C=N1 VGNVRWVRGFTTOF-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Claims (22)
1. Spoj, naznačen time, da ima formulu I:
[image]
gdje
X je O ili NH;
R1 je fenil, piridinil ili pirimidinil, od kojih je svaki supstituiran s 1, 2 ili 3 halogena,
R2 je H ili CH3 ili CF3;
svaki od R3, R4, R5 i R6 je neovisno sljedeći:
H,
C1-7-alkil, opcijski supstituiran s jednim ili više od halogena, cijano ili hidroksi, C1-7-alkoksi, opcijski supstituiran s jednim ili više halogena,
CN,
halogen,
NO2,
S-C1-7-alkil, S(O)-C1-7-alkil,
benziloksi, opcijski supstituiran s jednim ili više E, -C(O)-Ra, pri čemu Ra je hidroksi, C1-7-alkoksi, C1-7-alkil, fenoksi ili fenil, 3-člani do 7-člani heterociklil, opcijski supstituiran s jednim ili više A, -C(O)-NRbRc, pri čemu je svaki od Rb i Rc neovisno sljedeći:
H,
C1-7-alkil, opcijski supstituiran s jednim ili više od halogena, metila, -(CH2)t-hidroksi ili cijano,
-(CH2)t-C3-7-cikloalkil, opcijski supstituiran s jednim ili više B, i t je 0, 1, 2, 3, 4, 5 ili 6, -(CH2)u-O-C1-7-alkil, gdje u je 2, 3, 4, 5 ili 6,
-CHRi-C(O)ORii, pri čemu Ri je H, benzil ili C1-4-alkil, i Rii je H ili C1-7-alkil,
-S(O)2-C1-7-alkil ili -S(O)2-C3-7-cikloalkil,
-(CH2CH2O)vRiii, pri čemu v je od 1 do 3, i Riii je H ili C1-7-alkil,
-(CH2)w-heteroaril ili -(CH2)w-aril, svaki opcijski supstituiran s jednim ili više E, i gdje w je 0, 1, 2, 3 ili 4,
-(CH2)x-heterociklil, gdje x je 0, 1,2,3 ili 4, i pri čemu je heterociklil opcijski supstituiran s jednim ili više od sljedećih:
okso,
C1-7-alkil,
C3-7-cikloalkil, opcijski supstituiran s jednim ili više B,
CN,
benzil, opcijski supstituiran s jednim ili više E,
-(CH2)y-C(O)Riv, pri čemu y je 0, 1, 2, 3 ili 4, i Riv je hidroksi, C1-7-alkil ili C1-7-alkoksi,
-(CH2)z-C(O)NRvRvi, pri čemu z je 0, 1, 2, 3 ili 4, i Rv i Rvi su neovisno sljedeći:
vodik,
C1-7-alkil, opcijski supstituiran s jednim ili više halogena, OH ili CN,
C3-7-cikloalkil, opcijski supstituiran s jednim ili više B,
5-člani ili 6-člani heterociklil, opcijski supstituiran s jednim ili više A, ili
Rb i Rc zajedno s dušikom na kojega su vezani, tvore dio molekule heterociklila ili heteroarila, opcijski supstituiran s jednim ili više A, ili
Rb i Rc zajedno s dušikom na kojega su vezani, tvore 7-člani do 12-člani spirociklički heterocikl, opcijski supstituiran s jednim ili više A;
uz uvjet da Rb i Rc nisu istovremeno H,
A je hidroksi, okso, C1-7-alkil, C1-7-alkoksi, C1-7-haloalkil, C1-7-hidroksialkil, halogen ili CN;
B je halogen, hidroksi, CN, C1-4-alkil, benziloksi ili C1-4-haloalkil;
E je halogen, CN, NO2, hidroksi, C1-7-alkil, C1-7-alkoksi, C1-7-haloalkil, C1-7-hidroksialkil, C1-7-cijanoalkil, C1-7-haloalkoksi ili C3-7-cikloalkil;
pri čemu se izraz "heteroaril" odnosi na monovalentni aromatski 5-člani ili 6-člani monociklički prsten koji sadrži jedan, dva ili tri heteroatoma prstena odabrana od N, O ili S;
gdje se izraz "heterociklil" odnosi na monovalentni zasićeni ili djelomično zasićeni 3-člani do 7-člani monociklički ili 9-člani do 10-člani biciklički prstenasti sustav, pri čemu se jedan, dva, tri ili četiri atoma ugljika u prstenu zamjenjuju s N, O ili S, i s točkom priključenja na zasićenom ili djelomično nezasićenom prstenu od navedenog prstenastog sustava; ili njegova farmaceutski prihvatljiva sol.
2. Spoj prema zahtjevu 1, naznačen time, da R3 i R6 su H, halogen, CN ili C1-7-alkil.
3. Spoj prema zahtjevu 1 ili 2, naznačen time, da R4 je
C1-7-alkil, opcijski supstituiran s jednim ili više od halogena, cijano ili hidroksi,
C1-7-aIkoksi, opcijski supstituiran s jednim ili više halogena,
CN,
halogen,
NO2,
S-C1-7-alkil, S(O)-C1-7-alkil,
benziloksi. opcijski supstituiran s jednim ili više E,
-C(O)-Ra, pri čemu Ra je
hidroksi, C1-7-alkoksi, C1-7-alkil, fenoksi ili fenil, 3-člani do 7-člani heterociklil, opcijski supstituiran s jednim ili više A,
-C(O)-NRbRc, pri čemu je svaki od Rb i Rc neovisno sljedeći:
C1-7-alkil, opcijski supstituiran s jednim ili više od halogena, metila, -(CH2)t-hidroksi ili cijana,
-(CH2)t-C3-7-cikloalkil, opcijski supstituiran s jednim ili više B, i t je 0, 1, 2, 3, 4, 5 ili 6, -(CH2)u-O-C1-7-alkil, gdje u je 2, 3, 4, 5 ili 6,
-CHRi-C(O)ORii, pri čemu Ri je H, benzil ili C1-4-alkil, i Rii je H ili C1-7-alkil, -S(O)2-C1-7-alkil ili -S(O)2-C3-7-cikloalkil,
-(CH2CH2O)vRiii, pri čemu v je od 1 do 3, i Riii je H ili C1-7-alkil,
-(CH2)w-heteroaril ili -(CH2)w-aril, svaki opcijski supstituiran s jednim ili više E, i gdje w je 0, 1, 2, 3 ili 4,
-(CH2)x-heterociklil, gdje x je 0, 1, 2, 3 ili 4, i pri čemu je heterociklil opcijski supstituiran s jednim ili više od sljedećih:
okso,
C1-7-alkil,
C3-7-cikloalkil, opcijski supstituiran s jednim ili više B,
CN,
benzil, opcijski supstituiran s jednim ili više E,
-(CH2)y-C(O)Riv, pri čemu y je 0, 1, 2, 3 ili 4, i Riv je hidroksi, C1-7-alkil ili C1-7-alkoksi,
-(CH2)z-C(O)NRvRvi, pri čemu z je 0, 1, 2, 3 ili 4, i Rv i Rvi su neovisno sljedeći:
vodik,
C1-7-alkil, opcijski supstituiran s jednim ili više halogena, OH ili CN,
C3-7-cikloalkil, opcijski supstituiran s jednim ili više B,
5-člani ili 6-člani heterociklil, opcijski supstituiran s jednim ili više A, ili
Rb i Rc zajedno s dušikom na kojega su vezani, tvore dio molekule heterociklila ili heteroarila, opcijski supstituiran s jednim ili više A, ili
Rb i Rc zajedno s dušikom na kojega su vezani, tvore 7-člani do 12-člani spirociklički heterocikl, opcijski supstituiran s jednim ili više A;
uz uvjet da Rb i Rc nisu istovremeno H,
A je hidroksi, okso, C1-7-alkil, C1-7-alkoksi, C1-7-haloalkil, C1-7-hidroksialkil, halogen ili CN;
B je halogen, hidroksi, CN, C1-4-alkil, benziloksi ili C1-4-haloalkil;
E je halogen, CN, NO2, hidroksi, C1-7-alkil, C1-7-alkoksi, C1-7-haloalkil, C1-7-hidroksialkil,
C1-7-cijanoalkil, C1-7-haloalkoksi ili C3-7-cikloalkil;
ili njegova farmaceutski prihvatljiva sol.
4. Spoj prema zahtjevu 1, 2 ili 3, naznačen time, da R4 je -C(O)-NRbRc, pri čemu je svaki od Rb i Rc neovisno sljedeći:
C1-7-alkil, opcijski supstituiran s jednim ili više od halogena, metila, -(CH2)t-hidroksi ili cijana,
-(CH2)t-C3-7-cikloalkil, opcijski supstituiran s jednim ili više B, i t je 0, 1, 2, 3, 4, 5 ili 6, -(CH2)u-O-C1-7-alkil, gdje uje 2, 3, 4, 5 ili 6,
-CHRi-C(O)ORii, pri čemu Ri je H, benzil ili C1-4-alkil, i Rii je H ili C1-7-alkil,
-S(O)2-C1-7-alkil ili -S(O)2-C3-7-cikloalkil,
-(CH2CH2O)vRiii, pri čemu v je od 1 do 3, i Riii je H ili C1-7-alkil,
-(CH2)w-heteroaril ili -(CH2)w-aril, svaki opcijski supstituiran s jednim ili više E, i gdje w je 0, 1, 2, 3 ili 4,
-(CH2)x-heterociklil, gdje x je 0, 1, 2, 3 ili 4, i pri čemu je heterociklil opcijski supstituiran s jednim ili više od sljedećih:
okso,
C1-7-alkil,
C3-7-cikloaIkil, opcijski supstituiran s jednim ili više B,
CN,
benzil, opcijski supstituiran s jednim ili više E,
-(CH2)y-C(O)Riv, pri čemu y je 0, 1, 2, 3 ili 4, i Riv je hidroksi, C1-7-alkil ili C1-7-alkoksi,
-(CH2)z-C(O)NRvRvi, pri čemu z je 0, 1, 2, 3 ili 4, i Rv i Rvi su neovisno sljedeći:
vodik,
C1-7-alkil, opcijski supstituiran s jednim ili više halogena, OH ili CN,
C3-7-cikloalkil, opcijski supstituiran s jednim ili više B,
5-člani ili 6-člani heterociklil, opcijski supstituiran s jednim ili više A, ili
Rb i Rc zajedno s dušikom na kojega su vezani, tvore dio molekule heterociklila ili heteroarila, opcijski supstituiran s jednim ili više A, ili
Rb i Rc zajedno s dušikom na kojega su vezani, tvore 7-člani do 12-člani spirociklički heterocikl, opcijski supstituiran s jednim ili više A;
uz uvjet da Rb i Rc nisu istovremeno H,
A je hidroksi, okso, C1-7-alkil, C1-7-alkoksi, C1-7-haloalkil, C1-7-hidroksialkil, halogen ili CN;
B je halogen, hidroksi, CN, C1-4-alkil, benziloksi ili C1-4-haloalkil;
E je halogen, CN, NO2, hidroksi, C1-7-alkil, C1-7-alkoksi, C1-7-haloalkil, C1-7-hidroksialkil, C1-7-cijanoalkil, C1-7-haloalkoksi ili C3-7-cikloalkil;
ili njegova farmaceutski prihvatljiva sol.
5. Spoj prema zahtjevu 1, 2 ili 3, naznačen time, da R4 je sljedeći:
C1-7-alkil, opcijski supstituiran s jednim ili više od halogena, cijano ili hidroksi,
C1-7-alkoksi, opcijski supstituiran s jednim ili više halogena,
CN,
halogen,
NO2,
S-C1-7-alkil, S(O)-C1-7-alkil,
benziloksi, opcijski supstituiran s jednim ili više E,
E je halogen, CN, NO2, hidroksi, C1-7-alkil, C1-7-alkoksi, C1-7-haloalkil, C1-7-hidroksialkil, C1-7-cijanoalkil, C1-7-haloalkoksi ili C3-7-cikloalkil;
ili njegova farmaceutski prihvatljiva sol.
6. Spoj prema zahtjevu 1, 2 ili 3, naznačen time, da R4 je -C(O)-Ra, pri čemu Ra je hidroksi, C1-7-alkoksi, C1-7-alkil, fenoksi ili fenil.
7. Spoj prema zahtjevu 1, 2 ili 3, naznačen time, da R4 je 3-člani do 7-člani heterociklil, opcijski supstituiran s jednim ili više A, dok A je hidroksi, okso, C1-7-alkil, C1-7-alkoksi, C1-7-haloalkil, C1-7-hidroksialkil, halogen ili CN;
ili njegova farmaceutski prihvatljiva sol.
8. Spoj prema bilo kojem od zahtjeva 1 do 7, naznačen time, da R5 je sljedeći:
H,
C1-7-alkil, opcijski supstituiran s jednim ili više od halogena, hidroksi ili CN, benziloksi, opcijski supstituiran s jednim ili više E,
3-člani do 7-člani heterociklil, opcijski supstituiran s jednim ili više A,
-C(O)-NRbRc, pri čemu je svaki od Rb i Rc neovisno H,
A je hidroksi, okso, C1-7-alkil, C1-7-alkoksi, C1-7-haloalkil, C1-7-hidroksialkil, halogen ili CN;
E je halogen, CN, NO2, hidroksi, C1-7-alkil, C1-7-alkoksi, C1-7-haloalkil, C1-7-hidroksialkil, C1-7-cijanoalkil, C1-7-haloalkoksi ili C3-7-cikloalkil.
9. Spoj prema bilo kojem od zahtjeva 1 do 8, naznačen time, da je sljedeći:
2-metil-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin,
N-metil-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-etil-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(2-fluoro-etil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(2,2-difluoro-etil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-(2,2,2-trifluoro-etil)-nikotinamid,
N-(2-hidroksi-etil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
(R,S)-N-(2-hidroksi-propil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(3-metoksi-propil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-ciklopropilmetil-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(2-etil-butil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(4-cijano-tiazol-2-ilmetil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-piridin-2-ilmetil-nikotinamid,
N-(6-metil-3-okso-2,3-dihidro-piridazin-4-ilmetil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-izopropil-6-(5-metil-3-fcnil-izoksazol-4-ilmetoksi)-nikotinamid,
N-ciklopropil-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-ciklobutil-6-(5-metil-3-fenil-izoksazol-4-iIrnctoksi)-nikotinamid,
N-ciklopentil-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-(tetrahidro-piran-4-il)-nikotinamid,
(R,S)-N-(2,2-dimetil-tetrahidro-piran-4-il)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(1,1-diokso-heksahidro-l,6-tiopiran-4-il)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-(1-metil-piperidin-4-il)-nikotinamid,
N-(1-etil-piperidin-4-il)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(1-izopropil-piperidin-4-il)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(1-benzil-piperidin-4-il)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(1-etil-piperidin-3-il)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
(3-{[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-karbonil]-amino}-piperidin-1-il)-octena kiselina,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-{1-[(2,2,2-trifluoro-etilkarbamoil)-metil]-piperidin-3-il}-nikotinamid,
N-{1-[(2-hidroksi-etilkarbamoil)-metil]-piperidin-3-il}-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(4-fluoro-fenil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
4-benziloksi-2-(5-metil-3-fenilizoksazol-4-ilmetoksi)-piridin,
1-metil-2'-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-1,2,3,6-tetrahidro-[4,4']bipiridinil,
2-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-(2,2,2-trifluoro-etil)-izonikotinamid,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-(tetrahidro-piran-4-il)-4-trifluorometil- nikotinamid,
5-metil-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-(tetrahidro-piran-4-il)-nikotinamid,
N-izopropil-5-metil-6-(5-metil-3-feni]-izoksazol-4-ilmetoksi)-nikotinamid,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-(tetrahidro-furan-3-ilmetil)-nikotinamid,
[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-il]-(2-oksa-6-aza-spiro[3.3]hept-6-il)-metanon,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinska kiselina-izopropilester,
6-[3-(2-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(2,2,2-trifluoro-etil)-nikotinamid,
6-[3-(2-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(2,2,3,3,3-pentafluoro-propil)-nikotinamid,
6-[3-(2-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-izopropil-nikotinamid,
6-[3-(2-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(tctrahidro-piran-4-il)-nikotinamid,
6-[3-(3-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(2,2,2-trifluoro-etil)-nikotinamid,
N-ciklopropilmetil-6-[3-(3-fluoro-fenil)-5-metil-izoksazol-4-iImetoksi]-nikotinamid,
6-[3-(3-fluoro-fenil)-5-metil-izoksazo]-4-ilmetoksi]-N-izopropil-nikotinamid,
6-[3-(3-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi)-N-(tetrahidro-piran-4-il)-nikotinamid,
6-[3-(3-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(2,2,2-trifluoro-etil)-nikotinamid,
6-[3-(3-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-ciklopropilmetil-nikotinamid,
6-[3-(3-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-ciklopropil-nikotinamid,
6-[3-(3-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(tetrahidro-piran-4-il)-nikotinamid,
6-[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(2,2,2-trifluoro-etil)-nikotinamid,
N-ciklopropilmetil-6-[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-nikotinamid,
6-[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-izopropil-nikotinamid,
N-ciklopropil-6-[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-nikotinamid,
6-[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(tetrahidro-piran-4-il)-nikotinamid,
(1,1-diokso-1λ6-tiomorfolin-4-il)-{6-[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-metanon,
3-{6-[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-oksetan-3-ol,
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-nikotinska kiselina-metilester,
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi)-N-(2,2,2-trifluoro-etil)-nikotinamid,
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-ciklopropilmetil-nikotinamid,
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-izopropil-nikotinamid,
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-ciklopropil-nikotinamid,
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi)-N-(tetrahidro-piran-4-i])-nikotinamid,
{6-[3-(4-kloro-fenil)-5-mctil-izoksazol-4-ilmetoksi]-piridin-3-il}-(1,1-diokso-1λ6-tiomorfolin-4-il)-metanon,
{6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi)-piridin-3-il}-morfolin-4-il-metanon,
{6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-tiomorfolin-4-il-metanon,
6-[3-(3,4-difluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(2,2,2-trifluoro-etil)-nikotinamid,
6-[3-(3,4-difluoro-fenil)-5-metiI-izoksazol-4-ilmetoksi]-N-izopropil-nikotinamid,
6-[3-(3,4-difluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(tetrahidro-piran-4-il)-nikotinamid,
6-[3-(4-fluoro-fenil)-5-trifluorometiI-izoksazol-4-ilmetoksi]-N-(tetrahidro-piran-4-il)-nikotinamid,
6-(5-metil-3-piridin-4-il-izoksazol-4-ilmetoksi)-N-(2,2,2-trifluoro-etil)-nikotinamid,
N-ciklopropilmetil-6-(5-metil-3-piridin-4-il-izoksazol-4-ilmetoksi)-nikotinamid,
N-ciklopropil-6-(5-metil-3-piridin-4-il-izoksazoI-4-ilmetoksi)-nikotinamid,
N-izopropil-6-(5-metil-3-piridin-4-il-izoksazol-4-ilmetoksi)-nikotinamid,
6-(5-metil-3-piridin-4-il-izoksazol-4-ilmetoksi)-N-(tetrahidro-piran-4-il)-nikotinamid,
N-izopropil-6-[(5-metil-3-fenil-izoksazol-4-ilmetil)-amino]-nikotinamid,
6-[(5-metil-3-fenil-izoksazol-4-ilmetil)-amino]-N-(tetrahidro-piran-4-il)-nikotinamid,
6-{[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetil)-amino}-N-(2,2,2-trifluoro-etil)-nikotinamid,
N-ciklopropilmetil-6-{[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetil]-amino}-nikotinamid,
6-{[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetil]-amino}-N-izopropil-nikotinamid,
N-ciklopropil-6-{[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetil]-amino}-nikotinamid,
6-{[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetil]-amino}-N-(tetrahidro-piran-4-il)-nikotinamid,
N-(2-hidroksi-1,1-dimetil-etil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(2-metoksi-etil)-6-(5-metil-3-fenil-izoksazo]-4-ilmetoksi)-nikotinamid,
N-(1,1-diokso-tetrahidro-tiofen-3-il)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
6-(5-metil-3-fenil-izoksozol-4-ilmetoksi)-N-(3,3,3-trifluoro-2-hidroksi-propil)-nikotinamid,
(4-hidroksi-piperidin-1-il)-[6-(5-metil-3-fenil-izoksazol-4-ilmeloksi)-piridin-3-il]-metanon,
N-(3-hidroksi-2,2-dimetil-propil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(2-izopropoksi-etil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(2-hidroksi-1-metil-etil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
(3-hidroksi-azetidin-1-il)-[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-il]-metanon,
N-(2-hidroksi-cikloheksil)-6-(5-meti]-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(2-hidroksi-2-metil-propil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(1-hidroksi-ciklopropilmetil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid.
N-((R)-2-hidroksi-1-metil-etil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((S)-2-hidroksi-1-metil-etil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((1R,2R)-2-hidroksi-cikloheksil}-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((1S,2S)-2-hidroksi-cikloheksil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((1S,2R) i (1R,2S)-2-hidroksi-cikloheksil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(2-hidroksi-ciklopentil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(2-hidroksi-1-hidroksimetil-etil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-(S)-tetrahidro-furan-3-il-nikotinamid,
N-((1R,2S)-2-hidroksi-cikloheksil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid
N-((1S,2R)-2-hidroksi-ciklohcksil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((1S,2R)-2-hidroksi-cikloheksil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid
N-((1R,2S)-2-hidroksi-cikloheksil)-6-(5-metiI-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((S)-1-hidroksimetil-2-metil-propil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((S)-1-hidroksimetil-3-metil-butil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((S)-1-hidroksimetil-propil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((R)-1-hidroksimetil-propil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((1R,2S)-2-hidroksi-ciklopentil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid
N-((1S,2R)-2-hidroksi-ciklopentil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((1S,2R)-2-hidroksi-ciklopentil)-6-(5-meti]-3-fenil-izoksozol-4-ilmetoksi)-nikotinamid
ili
N-((1R,2S)-2-hidroksi-ciklopentil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((1S,2S)-2-hidroksi-ciklopentil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid
N-((1R,2R)-2-hidroksi-ciklopentil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-((1R,2R)-2-hidroksi-ciklopentil)-6-(5-metil-3-fenil-izoksazol-4-iImetoksi)-nikotinamid
N-((1S,2S)-2-hidroksi-ciklopentil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-[2-(2-okso-imidazolidin-1-il)-etil]-nikotinamid,
N-(3-hidroksi-butil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
3-{[6-(5-metl-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-karbonil]-amino}-azetidin-1-karboksilna kiselina-tert-butil-ester,
N-(2,3-dihidroksi-propil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(3-hidroksi-propil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(4-hidroksi-butil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(5-hidroksi-pentil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
N-(6-hidroksi-beksil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
(3-hidroksi-pirolidin-1-il)-[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-il]-metanon,
((S)-2-hidroksimetil-pirolidin-1-il)-[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-il]-metanon,
((R)-2-hidroksimetil-pirolidin-1-il)-[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-il]-metanon,
N-(3-benziloksi-ciklobutil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-il]-(2-metil-pirolidin-1-il)-metanon,
[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-il]-pirolidin-1-il-metanon,
(S)-2-{[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-karbonil]-amino}-3-fenilpropionska kiselina-metilester,
(cis ili trans)-N-(3-benziloksi-ciklobutil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
(S)-2-{(6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-karbonil]-amino}-3-fenilpropionska kiselina,
N-(3-metil-oksetan-3-il)-6-(5-metiI-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
butan-1-sulfonska kiselina-[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-karbonil]-amid,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-(2,2,2-trifluoro-1-metil-etil)-nikotinamid,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-((S)-2,2,2-trifluoro-1-metil-etil)-nikotinamid,
ciklopropansulfonska kiselina-metil-[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-karbonil]-amid,
6-(5-meti]-3-fenil-izoksazol-4-ilmetoksi)-N-(1-metil-1H-pirazol-4-il)-nikotinamid,
1-[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-karbonil]-1,2-dihidro-pirazol-3-on,
N-(1-metil-ciklopropil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
azetidin-1-il-(6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-il]-metanon,
(3-metoksi-azetidin-1l-il)-[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-il]-metanon,
[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-il]-tiazolidm-3-il-metanon,
N-(1-cijano-ciklopropil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-N-(1-metil-1H-pirazol-3-il)-nikotinamid,
2-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-5-metilsulfanil-piridin,
5-metansulfiniI-2-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin,
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(2-hidroksi-1,1-dimetil-etil)-nikotinamid,
6-(3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(1-metil-1H-pirazol-4-il)-nikotinamid,
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-((R)-2-hidroksi-1-metil-etiI)-nikotinamid,
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-((S)-2-hidroksi-1-metil-etil)-nikotinamid,
6-(3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-((S)-2,2,2-trifluoro-1-metil-etil)-nikotinamid,
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-((1R,2R)-2-hidroksi-ciklopentil)- nikotinamid
6-(3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-((1S,2S)-2-hidroksiciklopentil)-nikotinamid,
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-((1S,2S)-2-hidroksi-ciklopentil)-nikotinamid
6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-((1R,2R)-2-hidroksi-ciklopentil)-nikotinamid,
6-[3-(2,3-difluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-izopropil-nikotinamid,
6-[3-(2,3-difluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(tetrahidro-piran-4-il)-nikotinamid,
6-[3-(2,4-difluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-izopropil-nikotinamid,
6-[3-(2,4-difluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(tetrahidro-piran-4-il)-nikotinamid,
6-(3-(2,5-difluoro-fenil)-5-metil-izoksazol-4-ilmetoksi)-N-izopropil-nikotinamid,
6-(3-(2,5-difIuoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(tetrahidro-piran-4-il)-nikotinamid,
6-(3-(3,4-difluoro-fenil)-5-metil-izoksazol-4-ilmetoksiJ-N-(2-hidroksi-1,1-dimetil-etil)-nikotinamid,
6-(3-(3,4-difluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(3-hidroksi-2,2-dimetilpropil)-nikotinamid,
6-[3-(3,4-difIuoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-(2-hidroksi-2-metil-propil)-nikotinamid,
6-(3-(4-kloro-2-fluoro-fenil)-5-metil-izoksazol-4-iImetoksi]-N-izopropil-nikotinamid,
6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinska kiselina-metilester,
6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-N-(tetrahidro-piran-4-il)-nikotinamid,
N-izopropil-6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
(6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-piridin-3-i]]-morfolin-4-il-metanon,
6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-N-(2,2,2-trifluoro-etil)-nikotinamid,
(1,1-diokso-1,6-tiomorfolin-4-il)-[6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-piridin-3-il]-metanon,
N-ciklopropilmetil-6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
N-ciklopropil-6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
metil-6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
etil-6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
(2-hidroksi-1,1-dimetil-etil)-6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
(6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-piridin-3-il]-tiomorfolin-4-il-metanon,
6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinska kiselina,
(2-hidroksi-etil)-6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
(2-metoksi-etiI)-6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
6-(3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-nikotinska kiselina-metilester,
6-(3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-nikotinska kiselina,
6-[3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-(tetrahidro-piran-4-il)-nikotinamid,
6-(3-(5-fluoro-piridin-2-il )-5-metil-izoksazol-4-ilmetoksi]-izopropil-nikotinamid,
ciklopropil-6-(3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-nikotinamid,
6-(3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi](2-hidroksi-1,1-dimetil-etil)-nikotinamid,
ciklopropilmetil-6-(3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-nikotinamid,
(1,1-diokso-1,6-tiomorfolin-4-il)-{6-[3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-metanon,
6-[3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi)-2,2,2-trifluoro-etil)-nikotinamid,
6-[3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-(2-hidroksi-etil)-nikotinamid,
{6-[3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-morfoIin-4-il-metanon,
etil-6-[3-(5-fluoro-piridin-2-il)-5-metil-izoksazoI-4-ilmetoksi]-nikotinamid,
6-(3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-metil-nikotinamid,
6-(3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-N-((S)-2,2,2-trifluoro-1-metiletil)-nikotinamid,
6-(3-(5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-nikotinska kiselina-metilester,
6-[3-(5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-(tetrahidro-piran-4-il)-nikotinamid,
6-(3-(5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-izopropil-nikotinamid,
6-(3-(5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-ciklopropil-nikotinamid,
6-[3-{5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-nikotinska kiselina,
6-(3-(5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi)-(2-hidroksi-1,1-dimetil-etil)-nikotinamid,
6-(3-(5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi)-ciklopropilmetil-nikotinamid,
{6-[3-(5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-(1,1-diokso-1,6-tiomorfolin-4-il)-metanon,
6-[3-(5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-(2,2,2-trifluoro-etil)-nikotinamid,
{6-[3-(5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-morfolin-4-il-metanon,
{6-[3-(5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-tiomorfolin-4-il-metanon,
6-[3-{5-kloro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-(2-hidroksi-etil)-nikotinamid,
6-(5-metil-3-pirimidin-4-il-izoksazol-4-ilmetoksi)-nikotinska kiselina-metilester,
N-izopropil-6-(5-metil-3-pirimidin-4-il-izoksazol-4-ilmetoksi)-nikotinamid,
N-ciklopropil-6-(5-metil-3-pirimidin-4-il-izoksazol-4-ilmetoksi)-nikotinamid,
N-(2-hidroksi-1,1-dimetil-etil)-6-(5-metil-3-pirimidin-4-il-izoksazol-4-ilmetoksi)-nikotinamid,
(6-(5-metil-3-pirimidin-4-il-izoksazol-4-ilmetoksi)-piridin-3-il]-morfolin-4-il-metanon,
N-etil-6-(5-metil-3-pirimidin-4-il-izoksazol-4-ilmetoksi)-nikotinamid,
N-metil-6-(5-metil-3-pirimidin-4-il-izoksazol-4-ilmetoksi)-nikotinamid,
[6-(5-metil-3-pirimidin-4-il-izoksazol-4-ilmetoksi)-piridin-3-il]-tiomorfolin-4-il-metanon,
N-(2-hidroksi-etil)-6-(5-metil-3-pirimidin-4-il-izoksazol-4-ilmetoksi)-nikotinamid,
N-izopropil-6-(3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
6-(3-fenil-izoksazol-4-ilmetoksi)-N-(tetrahidro-piran-4-il)-nikotinamid,
6-[3-{4-fluoro-fenil)-izoksazol-4-ilmetoksi]-N-izopropiI-nikotinamid,
6-[3-(4-fluoro-fenil)-izoksazol-4-iImetoksi]-N-(tetrahidro-piran-4-il)-nikotinamid,
6-[3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-N-(2-hidroksi-1-metiI-etil)-nikotinamid,
6-[3-(4-fluoro-fenil)-izoksazoI-4-ilmetoksi]-N-((R)-2-hidroksi-1-metil-etil)-nikotinamid,
6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksil-N-((S)-2-hidroksi-1-metil-etil)-nikotinamid,
N-ciklopropilmetil-6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-nikotinamid,
N-ciklopropil-6-[3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-nikotinamid,
6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi)-N-(2,2,2-trifluoro-elil)-nikotinamid,
6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-N-((1S,2S)-2-hidroksi-ciklopentil)-nikotinamid,
6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-N-((1R,2R)-2-hidroksi-ciklopentil)-nikotinamid
6-[3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-N-((1S,2S)-2-hidroksi-ciklopentil)-nikotinamid,
6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-N-(2-hidroksi-1-hidroksimetil-etil)-nikotinamid,
6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-N-(2-metoksi-etil)-nikotinamid,
6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-N-((R)-2-hidroksi-propil}-nikotinamid,
6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-N-(2-hidroksi-etil)-nikotinamid,
6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-N-(1-hidroksi-ciklopropilmetil)-nikotinamid,
N-(1,1-diokso-tetrahidro-1,6-tiofen-3-il)-6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-nikotinamid,
6-(3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-N-((1R,2R)-2-hidroksi-ciklopentil)-nikotinamid
6-[3-(4-fluorofenil)-izoksazol-4-ilmetoksi]-N-((1S,2S)-2-hidroksi-ciklopentil)-nikotinamid,
6-[3-(4-kIoro-fenil)-izoksazol-4-ilmetoksi)-N-(2,2,2-trifluoro-etil)-nikotinamid,
6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-N-ciklopropil-nikotinamid,
6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-N-izopropil-nikotinamid,
6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-N-(tetrahidro-piran-4-il)-nikotinamid,
6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-N-(2-hidroksi-etil)-nikotinamid,
6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-N-(2-hidroksi-propil)-nikotinamid,
6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-N-(3-hidroksi-propil)-nikotinamid,
6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-N-(2-hidroksi-1,1-dimetil-etil)-nikotinamid,
6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-N-(3-hidroksi-2,2-dimetil-propil)-nikotinamid,
3-({6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-piridin-3-karbonil}-amino)-azetidin-1-karboksilna kiselina-tert-butil-ester,
6-(3-(4-kloro-fenil)-izoksazol-4-ilmetoksi)-N-((1S,2R)-2-hidroksi-ciklopentil)-nikotinamid
6-[3-(4-kloro-fenil)-izoksazol-4-iImetoksi]-N-((1R2R)-2-hidroksi-ciklopentil)-nikotinamid,
6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-N-(2-hidroksi-1-hidroksimetil-etil)-nikotinamid,
6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-N-((R)-2-hidroksi-1-metil-etil)-nikotinamid,
6-(3-(4-kloro-fenil)-izoksazol-4-iImetoksi)-N-((S)-2-hidroksi-1-meti]-etil)-nikotinamid,
6-(3-(4-kloro-fenil)-izoksazol-4-ilmetoksi)-N-((S)-2,2,2-trifluoro-1-metil-etil)-nikotinamid,
6-(3-piridin-2-il-izoksazol-4-ilmetoksi)-N-(tetrahidro-piran-4-il)-nikotinamid,
N-izopropil-6-(3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
N-ciklopropil-6-(3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
N-ciklopropilmetil-6-(3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
6-(3-piridin-2-il-izoksazol-4-ilmetoksi)-N-(2,2,2-trifluoro-etil)-nikotinamid,
N-(2-hidroksi-etil)-6-(3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
N-etil-6-(3-piridin-2-il-izoksazol-4-ilmetoksi)-nikotinamid,
6-[3-(5-fluoro-piridin-2-il)-izoksazol-4-ilmetoksi]-(tetrahidro-piran-4-il)-nikotinamid,
6-[3-(5-fluoro-piridin-2-il)-izoksazol-4-ilmetoksi]-izopropiI-nikotinamid,
ciklopropil-6-[3-(5-fluoro-piridin-2-il)-izoksazol-4-ilmetoksi]-nikotinamid,
6-[3-(5-fluoro-piridin-2-il)-izoksozol-4-ilmetoksi]-(2-hidroksi-1,1-dimetil-etil)-nikotinamid,
6-[3-(5-fluoro-piridin-2-il)-izoksazol-4-ilmetoksi]-(2,2,2-trifluoro-etil)-nikotinamid,
6-(3-(5-fluoro-piridin-2-il)-izoksazol-4-ilmetoksi]-(2-hidroksi-etil)-nikotinamid,
etil-6-[3-(5-fluoro-piridin-2-il)-izoksazol-4-ilmetoksi]-nikotinamid
6-[3-(5-fluoro-piridin-2-il)-izoksazol-4-ilmetoksi]-metil-nikotinamid.
10. Spoj prema bilo kojem od zahtjeva 1 do 9, naznačen time, da spoj je N-izopropil-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid ili njegova farmaceutski prihvatljiva sol.
11. Spoj prema bilo kojem od zahtjeva 1 do 9, naznačen time, da spoj je (1,1-diokso-1λ6-tiomorfolin-4-il)-{6-[3-(4-fluoro-fenil)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-metanon ili njegova farmaceutski prihvatljiva sol.
12. Spoj prema bilo kojem od zahtjeva 1 do 9, naznačen time, da spoj je {6-[3-(4-kloro-fenil)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-morfolin-4-il-metanon ili njegova farmaceutski prihvatljiva sol.
13. Spoj prema bilo kojem od zahtjeva 1 do 9, naznačen time, da spoj je [6-(5-metil-3-piridin-2-il-izoksazol-4-ilmetoksi)-piridin-3-il]-morfolin-4-il-metanon ili njegova farmaceutski prihvatljiva sol.
14. Spoj prema bilo kojem od zahtjeva 1 do 9, naznačen time, da spoj je 6-[3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-izopropil-nikotinamid ili njegova farmaceutski prihvatljiva sol.
15. Spoj prema bilo kojem od zahtjeva 1 do 9, naznačen time, da spoj je (1,1-diokso-1λ6-tiomorfolin-4-il)-{6-[3-(5-fluoro-piridin-2-il)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-metanon ili njegova farmaceutski prihvatljiva sol.
16. Spoj prema bilo kojem od zahtjeva 1 do 9, naznačen time, da spoj je {6-[3-(5-kloro-fenil-2-il)-5-metil-izoksazol-4-ilmetoksi]-piridin-3-il}-tiomorfolin-4-il-metanon ili njegova farmaceutski prihvatljiva sol.
17. Spoj, naznačen time, da je odabran od sljedećih:
N-(2-acetilamino-etil)-6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-nikotinamid,
(2-{[6-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-piridin-3-karbonil]-amino}-etil)-karbaminska kiselina-tert-butil-ester,
6-(5-metil-3-m-tolil-izoksazol-4-ilmetoksi)-N-(tetrahidro-piran-4-il)-nikotinamid,
N-izopropil-6-(5-metil-3-m-tolil-izoksazol-4-ilmetoksi)-nikotinamid,
6-(5-metil-3-p-tolil-izoksazol-4-ilmetoksi)-N-(tetrahidro-piran-4-il)-nikotinamid,
N-izopropil-6-(5-metil-3-p-tolil-izoksazol-4-ilmetoksi)-nikotinamid,
6-[3-(2-fIuoro-4-metil-fenil)-5-metil-izoksazol-4-ilmetoksi]-N-izopropil-nikotinamid,
N-(2-acetilamino-etil)-6-[3-(4-fluoro-fenil)-izoksazol-4-ilmetoksi]-nikotinamid,
N-(2-acetilamino-etil)-6-[3-(4-kloro-fenil)-izoksazol-4-ilmetoksi]-nikotinamid,
5-(3-metil-[1,2,4]oksadiazol-5-il)-2-(5-metil-3-fenil-izoksazol-4-ilrnetoksi)-piridin i 2-(5-metil-3-fenil-izoksazol-4-ilmetoksi)-5-(5-metil-4H-[1,2,4]triazol-3-il)-piridin.
18. Postupak za proizvodnju spoja formule 1
[image]
gdje X je O, a R1 do R6 su definirani prema zahtjevu 1, naznačen time, da obuhvaća sljedeće korake:
a) reakcija spoja formule XIV
[image]
sa spojem formule XV
[image]
u prisutnosti baze, u otapalu, ili alternativno
b) reakcija spoja formule XIV sa spojem formule XVI
[image]
u prisutnosti trifenilfosfina i dietilazodikarboksilata, u otapalu.
19. Postupak za proizvodnju spoja formule Ic
[image]
gdje R4 je -C(O)OH ili -C(O)OMe, ili gdje R4 je -C(O)NRbRc kako je definirano prema zahtjevu 1, naznačen time, da obuhvaća sljedeće korake:
a) reakcija spoja formule XIX
[image]
s metil-6-kloronikotinatom, u prisutnosti baze, u prikladnom otapalu, za dobivanje spoja formule I-c';
[image]
b) opcijski zatim slijedi hidroliza estera za dobivanje spoja formule I-c",
[image]
c) uzastopna opcijska rcakcija amidacije spoja formule 1-c" s aminom formule RbRcNH u otapalu,
za dobivanje spoja formule Ic, gdje R4 je -C(O)NRbRc kako je definirano prema zahtjevu 1, ili alternativno
d) reakcija spoja formule I-c' s Mc3Al,
s aminom formule RbRcNH u otapalu,
za dobivanje spoja formule Ic, gdje R4 je -C(O)NRbRc kako je definirano prema zahtjevu 1.
20. Lijek, naznačen time, da sadrži najmanje jedan spoj formule I prema bilo kojem od zahtjeva 1 do 17.
21. Uporaba spoja formule I prema bilo kojem od zahtjeva 1 do 17, naznačena time, da je za proizvodnju lijeka koji je koristan kao kognitivni pobuđivač ili je za proizvodnju lijeka za liječenje kognitivnih poremećaja.
22. Uporaba spoja formule I prema zahtjevu 21, naznačena time, da je za proizvodnju lijeka za liječenje Alzheimerove bolesti.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07122240 | 2007-12-04 | ||
EP08857137.7A EP2227467B1 (en) | 2007-12-04 | 2008-11-26 | Isoxazolo-pyridine derivatives |
PCT/EP2008/066225 WO2009071476A1 (en) | 2007-12-04 | 2008-11-26 | Isoxazolo-pyridine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20150348T1 true HRP20150348T1 (hr) | 2015-05-08 |
Family
ID=40329314
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20150348TT HRP20150348T1 (hr) | 2007-12-04 | 2015-03-27 | Derivati izoksazolo-piridina |
HRP20151250TT HRP20151250T1 (hr) | 2007-12-04 | 2015-11-20 | Derivati izoksazolo-piridina |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20151250TT HRP20151250T1 (hr) | 2007-12-04 | 2015-11-20 | Derivati izoksazolo-piridina |
Country Status (34)
Country | Link |
---|---|
US (6) | US20090143371A1 (hr) |
EP (2) | EP2227467B1 (hr) |
JP (1) | JP5301557B2 (hr) |
KR (2) | KR20120102117A (hr) |
CN (1) | CN101889010B (hr) |
AR (1) | AR069523A1 (hr) |
AU (1) | AU2008333326B2 (hr) |
BR (1) | BRPI0820112B8 (hr) |
CA (1) | CA2707648C (hr) |
CL (1) | CL2008003591A1 (hr) |
CO (1) | CO6351788A2 (hr) |
CR (1) | CR11454A (hr) |
CY (2) | CY1116119T1 (hr) |
DK (2) | DK2227467T3 (hr) |
EC (1) | ECSP10010230A (hr) |
ES (2) | ES2550994T3 (hr) |
HK (1) | HK1149756A1 (hr) |
HR (2) | HRP20150348T1 (hr) |
HU (1) | HUE025545T2 (hr) |
IL (1) | IL205759A (hr) |
MA (1) | MA31865B1 (hr) |
MX (1) | MX2010005717A (hr) |
MY (1) | MY156747A (hr) |
NZ (1) | NZ585308A (hr) |
PE (2) | PE20130242A1 (hr) |
PL (2) | PL2227467T3 (hr) |
PT (2) | PT2767536E (hr) |
RS (2) | RS53877B1 (hr) |
RU (1) | RU2484091C2 (hr) |
SI (2) | SI2767536T1 (hr) |
TW (1) | TWI363624B (hr) |
UA (1) | UA100132C2 (hr) |
WO (1) | WO2009071476A1 (hr) |
ZA (1) | ZA201003631B (hr) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2227467T3 (pl) | 2007-12-04 | 2015-05-29 | Hoffmann La Roche | Pochodne izoksazolo-pirydyny |
US20100216827A1 (en) * | 2008-10-21 | 2010-08-26 | Metabolex, Inc. | Aryl gpr120 receptor agonists and uses thereof |
US8748623B2 (en) | 2009-02-17 | 2014-06-10 | Syntrix Biosystems, Inc. | Pyridinecarboxamides as CXCR2 modulators |
US8389550B2 (en) * | 2009-02-25 | 2013-03-05 | Hoffmann-La Roche Inc. | Isoxazoles / O-pyridines with ethyl and ethenyl linker |
US8222246B2 (en) * | 2009-04-02 | 2012-07-17 | Hoffmann-La Roche Inc. | Substituted isoxazoles |
US20100280019A1 (en) * | 2009-04-30 | 2010-11-04 | Roland Jakob-Roetne | Isoxazoles |
WO2010127976A1 (en) * | 2009-05-05 | 2010-11-11 | F. Hoffmann-La Roche Ag | Isoxazole-pyridine derivatives |
AU2010244552A1 (en) * | 2009-05-05 | 2011-09-29 | F. Hoffmann-La Roche Ag | Isoxazole-pyrazole derivatives |
CA2759598C (en) * | 2009-05-05 | 2017-09-12 | F. Hoffmann-La Roche Ag | Isoxazole-thiazole derivatives as gaba a receptor inverse agonists for use in the treatment of cognitive disorders |
SG175318A1 (en) | 2009-05-07 | 2011-11-28 | Hoffmann La Roche | Isoxazole-pyridine derivatives as gaba modulators |
RU2012116124A (ru) * | 2009-09-21 | 2013-10-27 | Вандербилт Юниверсити | О-БЕНЗИЛ НИКОТИНАМИДНЫЕ АНАЛОГИ КАК ПОЗИТИВНЫЕ АЛЛОСТЕРИЧЕСКИЕ МОДУЛЯТОРЫ mGluR5 |
AU2011210765A1 (en) | 2010-01-28 | 2012-09-13 | President And Fellows Of Harvard College | Compositions and methods for enhancing proteasome activity |
US20130252972A1 (en) | 2010-07-19 | 2013-09-26 | Syngenta Crop Protection Llc | Isoxazole, isothiazole, furane and thiophene compounds as microbicides |
US20130210836A1 (en) | 2010-07-19 | 2013-08-15 | Syngenta Crop Protection Llc | Microbicides |
US8779149B2 (en) | 2010-08-23 | 2014-07-15 | Syntrix Biosystems, Inc. | Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulators |
EP2457569A1 (en) | 2010-11-05 | 2012-05-30 | F. Hoffmann-La Roche AG | Use of active pharmaceutical compounds for the treatment of central nervous system conditions |
WO2012059482A1 (en) * | 2010-11-05 | 2012-05-10 | F. Hoffmann-La Roche Ag | Use of active pharmaceutical compounds for the treatment of central nervous system conditions |
CN103635230B (zh) | 2011-05-12 | 2017-10-31 | 普罗蒂斯特斯治疗公司 | 蛋白内稳态调节剂 |
US8604062B2 (en) * | 2011-10-20 | 2013-12-10 | Hoffman-La Roche Inc. | Process for the preparation of isoxazolyl-methoxy nicotinic acids |
US8785435B2 (en) * | 2011-10-20 | 2014-07-22 | Hoffmann-La Roche Inc. | Solid forms |
ES2790358T3 (es) | 2011-12-28 | 2020-10-27 | Global Blood Therapeutics Inc | Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular |
PT3738434T (pt) | 2011-12-28 | 2023-11-13 | Global Blood Therapeutics Inc | Intermediários para obter compostos de benzaldeído substituído e métodos para a sua utilização no aumento da oxigenação de tecidos |
US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
EP2877463B1 (en) * | 2012-06-26 | 2018-11-07 | Saniona A/S | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
US9475797B2 (en) | 2012-06-26 | 2016-10-25 | Saniona A/S | Phenyl triazole derivative and its use for modulating the GABAA receptor complex |
WO2014001280A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
WO2014001279A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
WO2014001278A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
WO2014116228A1 (en) | 2013-01-25 | 2014-07-31 | President And Fellows Of Harvard College | Usp14 inhibitors for treating or preventing viral infections |
US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
CN105073728A (zh) | 2013-03-15 | 2015-11-18 | 全球血液疗法股份有限公司 | 化合物及其用于调节血红蛋白的用途 |
US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
EA033555B1 (ru) * | 2013-03-15 | 2019-10-31 | Global Blood Therapeutics Inc | Фармацевтические композиции для лечения серповидно-клеточного нарушения |
US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
PE20160078A1 (es) | 2013-03-15 | 2016-03-02 | Global Blood Therapeutics Inc | Compuestos y sus usos para modular la hemoglobina |
EP2792360A1 (en) | 2013-04-18 | 2014-10-22 | IP Gesellschaft für Management mbH | (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV |
US10561676B2 (en) | 2013-08-02 | 2020-02-18 | Syntrix Biosystems Inc. | Method for treating cancer using dual antagonists of CXCR1 and CXCR2 |
US8969365B2 (en) | 2013-08-02 | 2015-03-03 | Syntrix Biosystems, Inc. | Thiopyrimidinecarboxamides as CXCR1/2 modulators |
US10046002B2 (en) | 2013-08-02 | 2018-08-14 | Syntrix Biosystems Inc. | Method for treating cancer using chemokine antagonists |
WO2015073528A1 (en) | 2013-11-12 | 2015-05-21 | Proteostasis Therapeutics, Inc. | Proteasome activity enhancing compounds |
EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
MY189995A (en) | 2014-02-07 | 2022-03-22 | Global Blood Therapeutics Inc | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
JP2017071553A (ja) * | 2014-02-25 | 2017-04-13 | 味の素株式会社 | ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物 |
MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
CN106810542B (zh) * | 2015-11-30 | 2021-03-09 | 苏州开拓药业股份有限公司 | 一种硫代咪唑烷酮化合物的晶型、盐型及其制备方法 |
US11020382B2 (en) | 2015-12-04 | 2021-06-01 | Global Blood Therapeutics, Inc. | Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
AR108435A1 (es) | 2016-05-12 | 2018-08-22 | Global Blood Therapeutics Inc | Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído |
TWI778983B (zh) | 2016-10-12 | 2022-10-01 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
US10660909B2 (en) | 2016-11-17 | 2020-05-26 | Syntrix Biosystems Inc. | Method for treating cancer using chemokine antagonists |
HRP20220468T1 (hr) * | 2016-12-08 | 2022-05-27 | F. Hoffmann - La Roche Ag | Novi derivati izoksazolil etera kao gaba a alpha5 pam |
CA3074110A1 (en) * | 2017-08-28 | 2019-03-07 | University Of Maryland, Baltimore | Novel gamma aminobutyric acid type a receptor modulators for mood disorders |
CA3086792A1 (en) * | 2017-12-22 | 2019-06-27 | Bayer Aktiengesellschaft | Hydroxyisoxazolines and derivatives thereof |
MX2020013518A (es) * | 2018-06-13 | 2021-02-26 | Hoffmann La Roche | Nuevos derivados de isoxazolil eter como moduladores alostericos positivos (pam) del receptor de acido gamma-aminobutirico a alfa5 (gaba a alfa5). |
BR102019014802A2 (pt) | 2018-07-20 | 2020-02-04 | Boehringer Ingelheim Int | difluorometil-fenil triazóis |
HU231223B1 (hu) | 2018-09-28 | 2022-01-28 | Richter Gedeon Nyrt. | GABAA A5 receptor modulátor hatású biciklusos vegyületek |
ES2966707T3 (es) | 2018-10-01 | 2024-04-23 | Global Blood Therapeutics Inc | Moduladores de la hemoglobina para el tratamiento de la drepanocitosis |
EP4126858A1 (en) | 2020-03-26 | 2023-02-08 | Richter Gedeon Nyrt. | Dihydro-2-pyrrolo[3,4-c]pyridine derivatives as gabaa a5 receptor modulators |
EP4334301A1 (en) | 2021-05-05 | 2024-03-13 | University College Cardiff Consultants Limited | Heteroaryl compounds useful in the treatment of cognitive disorders |
CN116854680A (zh) * | 2022-03-28 | 2023-10-10 | 上海赛默罗生物科技有限公司 | 异噁唑-杂环类衍生物、药物组合物和用途 |
CN115286636A (zh) * | 2022-10-08 | 2022-11-04 | 上海赛默罗生物科技有限公司 | 烟酰胺晶型及其制备方法和用途 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3812225A1 (de) * | 1988-04-13 | 1989-10-26 | Basf Ag | Isoxazol(isothiazol)-5-carbonsaeureamide |
ES2255294T3 (es) | 1998-08-07 | 2006-06-16 | Chiron Corporation | Derivados de isoxazol sustituidos como moduladores del receptor de estrogenos. |
DE19920791A1 (de) * | 1999-05-06 | 2000-11-09 | Bayer Ag | Substituierte Benzoylisoxazole |
GB0125086D0 (en) | 2001-10-18 | 2001-12-12 | Merck Sharp & Dohme | Novel compounds |
WO2003099793A1 (en) | 2002-05-24 | 2003-12-04 | Takeda Pharmaceutical Company Limited | 1,2-azole derivatives with hypoglycemic and hypolipidemic activity |
GB0221443D0 (en) * | 2002-09-16 | 2002-10-23 | Glaxo Group Ltd | Pyridine derivates |
BRPI0511099A (pt) * | 2004-05-14 | 2007-12-26 | Irm Llc | compostos e composições como moduladores de ppar |
BRPI0516842A (pt) * | 2004-10-01 | 2008-09-23 | Hoffmann La Roche | compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por lxr alfa e/ou lxr beta agonistas e uso desses compostos |
EP1899299B1 (en) * | 2005-06-27 | 2010-10-20 | Bristol-Myers Squibb Company | C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
CA2623043A1 (en) * | 2005-09-19 | 2007-04-12 | F. Hoffman-La Roche Ag | Isoxazolo derivatives as gaba a alpha5 inverse agonists |
BRPI0617306A2 (pt) * | 2005-10-11 | 2011-07-19 | Hoffmann La Roche | derivados de isoxazol |
CA2633425A1 (en) * | 2005-12-23 | 2007-06-28 | F. Hoffmann-La Roche Ag | Aryl-isoxazolo-4-yl-oxadiazole derivatives |
JP2009521516A (ja) | 2005-12-27 | 2009-06-04 | エフ.ホフマン−ラ ロシュ アーゲー | アリール−イソオキサゾール−4−イル−イミダゾール誘導体 |
CA2633536A1 (en) | 2005-12-27 | 2007-07-05 | F. Hoffmann-La Roche Ag | Aryl-isoxazol-4-yl-imidazo[1, 5-a]pyridine derivatives |
RU2426732C2 (ru) | 2006-01-17 | 2011-08-20 | Ф. Хоффманн-Ля Рош Аг | АРИЛ-ИЗОКСАЗОЛ-4-ИЛ-ИМИДАЗО[1,2-a]ПИРИДИН, ПРИГОДНЫЙ ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА ЧЕРЕЗ ПОСРЕДСТВО GABA-РЕЦЕПТОРОВ |
US7943619B2 (en) | 2007-12-04 | 2011-05-17 | Hoffmann-La Roche Inc. | Isoxazolo-pyridazine derivatives |
PL2227467T3 (pl) | 2007-12-04 | 2015-05-29 | Hoffmann La Roche | Pochodne izoksazolo-pirydyny |
CA2706990C (en) | 2007-12-04 | 2016-05-10 | F. Hoffmann-La Roche Ag | Isoxazolo-pyrazine derivatives |
US20100280019A1 (en) * | 2009-04-30 | 2010-11-04 | Roland Jakob-Roetne | Isoxazoles |
-
2008
- 2008-11-26 PL PL08857137T patent/PL2227467T3/pl unknown
- 2008-11-26 RS RS20150176A patent/RS53877B1/en unknown
- 2008-11-26 PL PL14168581T patent/PL2767536T3/pl unknown
- 2008-11-26 SI SI200831532T patent/SI2767536T1/sl unknown
- 2008-11-26 ES ES14168581.8T patent/ES2550994T3/es active Active
- 2008-11-26 PT PT141685818T patent/PT2767536E/pt unknown
- 2008-11-26 AU AU2008333326A patent/AU2008333326B2/en active Active
- 2008-11-26 CA CA2707648A patent/CA2707648C/en active Active
- 2008-11-26 UA UAA201008007A patent/UA100132C2/ru unknown
- 2008-11-26 SI SI200831370T patent/SI2227467T1/sl unknown
- 2008-11-26 EP EP08857137.7A patent/EP2227467B1/en active Active
- 2008-11-26 BR BRPI0820112A patent/BRPI0820112B8/pt active IP Right Grant
- 2008-11-26 KR KR1020127018310A patent/KR20120102117A/ko not_active Application Discontinuation
- 2008-11-26 MY MYPI2010002566A patent/MY156747A/en unknown
- 2008-11-26 DK DK08857137.7T patent/DK2227467T3/en active
- 2008-11-26 RS RS20150703A patent/RS54355B1/en unknown
- 2008-11-26 WO PCT/EP2008/066225 patent/WO2009071476A1/en active Application Filing
- 2008-11-26 CN CN2008801193998A patent/CN101889010B/zh active Active
- 2008-11-26 PT PT08857137T patent/PT2227467E/pt unknown
- 2008-11-26 ES ES08857137T patent/ES2531023T3/es active Active
- 2008-11-26 RU RU2010123923/04A patent/RU2484091C2/ru active
- 2008-11-26 EP EP14168581.8A patent/EP2767536B1/en active Active
- 2008-11-26 NZ NZ585308A patent/NZ585308A/en unknown
- 2008-11-26 DK DK14168581.8T patent/DK2767536T3/en active
- 2008-11-26 HU HUE14168581A patent/HUE025545T2/en unknown
- 2008-11-26 KR KR1020107012058A patent/KR101237576B1/ko active IP Right Grant
- 2008-11-26 JP JP2010536409A patent/JP5301557B2/ja active Active
- 2008-11-26 MX MX2010005717A patent/MX2010005717A/es active IP Right Grant
- 2008-12-01 PE PE2012002214A patent/PE20130242A1/es not_active Application Discontinuation
- 2008-12-01 US US12/325,293 patent/US20090143371A1/en not_active Abandoned
- 2008-12-01 PE PE2008002002A patent/PE20091073A1/es active IP Right Grant
- 2008-12-01 TW TW097146632A patent/TWI363624B/zh active
- 2008-12-02 AR ARP080105242A patent/AR069523A1/es active IP Right Grant
- 2008-12-02 CL CL2008003591A patent/CL2008003591A1/es unknown
-
2010
- 2010-05-13 IL IL205759A patent/IL205759A/en active IP Right Grant
- 2010-05-14 CO CO10058230A patent/CO6351788A2/es active IP Right Grant
- 2010-05-21 CR CR11454A patent/CR11454A/es unknown
- 2010-05-21 ZA ZA2010/03631A patent/ZA201003631B/en unknown
- 2010-05-27 MA MA32871A patent/MA31865B1/fr unknown
- 2010-06-03 EC EC2010010230A patent/ECSP10010230A/es unknown
-
2011
- 2011-04-19 HK HK11103951.8A patent/HK1149756A1/xx unknown
-
2012
- 2012-02-10 US US13/370,444 patent/US8518974B2/en active Active
-
2013
- 2013-06-12 US US13/916,191 patent/US8877782B2/en active Active
- 2013-06-12 US US13/916,264 patent/US8877783B2/en active Active
- 2013-06-12 US US13/916,317 patent/US9073908B2/en active Active
- 2013-06-12 US US13/916,068 patent/US8846719B2/en active Active
-
2015
- 2015-03-16 CY CY20151100262T patent/CY1116119T1/el unknown
- 2015-03-27 HR HRP20150348TT patent/HRP20150348T1/hr unknown
- 2015-11-09 CY CY20151100999T patent/CY1116902T1/el unknown
- 2015-11-20 HR HRP20151250TT patent/HRP20151250T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20150348T1 (hr) | Derivati izoksazolo-piridina | |
AU2017200801B2 (en) | Pyridin- 2 -amides useful as CB2 agonists | |
JP5328640B2 (ja) | 6−o−置換ベンゾオキサゾールおよびベンゾチアゾール化合物ならびにcsf−1rシグナル伝達を阻害する方法 | |
EP2616465B1 (en) | Triazine-oxadiazoles | |
ES2261658T3 (es) | Antagonistas nmda/nr2b heterociclicos no arilicos n-sustituidos. | |
FI3820573T3 (fi) | 3-(5-hydroksi-1-oksoisoindolin-2-yyli)piperidiini-2,6-dionijohdannaisia ja niiden käyttö ikaros-perheen sinkkisormi 2 (ikzf2) -riippuvaisten sairauksien hoidossa | |
US9452986B2 (en) | 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use | |
AU2008279097B2 (en) | Triazine kinase inhibitors | |
JP2017524007A5 (hr) | ||
CN113453679A (zh) | 靶向蛋白降解 | |
US20210387966A1 (en) | 2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors | |
CN101675051A (zh) | 吡唑并嘧啶类似物及其作为mTOR激酶和PI3激酶抑制剂的用途 | |
CA2873060A1 (en) | Nampt inhibitors | |
JP2016523911A5 (hr) | ||
CA2873097A1 (en) | Pyridazine and pyridine derivatives as nampt inhibitors | |
HRP20140265T1 (hr) | Derivat aminopirazina i odgovarajuä†i lijek | |
CA2816594A1 (en) | Nampt and rock inhibitors | |
JP2013542265A5 (hr) | ||
JP2019530739A5 (hr) | ||
AU2013278873B2 (en) | 1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives | |
CN117285525A (zh) | 作为GABAAα5 PAM的新型异噁唑基醚衍生物 | |
CA2905530A1 (en) | Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors | |
CN110526929A (zh) | 芳杂环化合物、其药物组合物及其应用 | |
CN111655695A (zh) | 作为pde1抑制剂的取代的呋喃并嘧啶化合物 | |
RU2018117503A (ru) | ЗАМЕЩЕННЫЕ ИНДАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ RORγТ И ИХ ПРИМЕНЕНИЕ |